Maple Leaf Foods Reports Second Quarter 2025 Financial Results
7 augusti, 11:59
7 augusti, 11:59
Maple Leaf Foods Reports Second Quarter 2025 Financial Results
PR Newswire
MISSISSAUGA, ON, Aug. 7, 2025
TSX: MFI
Maple Leaf Foods reports Revenue growth of 8.5%, Adjusted EBITDA growth of 28.9%, and increases its fiscal 2025 Adjusted EBITDA outlook
MISSISSAUGA, ON , Aug. 7, 2025 /PRNewswire/ - Maple Leaf Foods Inc. ("Maple Leaf Foods" or the "Company") (TSX: MFI) today reported its financial results for the second quarter ended June 30, 2025.
Second Quarter Highlights
Executive Commentary
"The momentum in our business continued in the second quarter, delivering strong results with sales growth of over 8% and Adjusted EBITDA of $182 million , an increase of $41 million or 29% from the prior year," said Curtis Frank , President and Chief Executive Officer of Maple Leaf Foods. "This performance was fueled by improved profitability in the pork complex and profitable growth in our brand-led consumer packaged goods business, resulting in an Adjusted EBITDA margin of 13.3%, a year-over-year improvement of 210 basis points, and the further strengthening of our balance sheet. With a strong first half now behind us, we are well-positioned to deliver on our increased full-year 2025 Adjusted EBITDA outlook," added Mr. Frank.
"In parallel, we continue to make excellent progress toward completing the spin-off of Canada Packers, supported by resounding shareholder approval and accelerating operational readiness," Frank added. "This historic transaction will unlock significant shareholder value and establish two focused, market-leading companies. We remain firmly on track to complete the transaction in the second half of the year, delivering long-term value for all our stakeholders," concluded Mr. Frank.
Update on the Spin-off of Canada Packers
The Company is continuing to advance its operational readiness for the spin-off of its Pork Operations to create Canada Packers Inc. as a stand-alone public company. The transaction, which was approved by shareholders in June, will be implemented as a tax-free "butterfly reorganization" by way of a plan of arrangement and, subject to receipt of an advance tax ruling from the Canada Revenue Agency and final TSX approval, is on track to be completed in the last half of 2025 as planned.
Outlook
(i) | Maple Leaf reorganized its operating units in the first quarter as further defined in the section titled Financial Highlights. |
(ii) | Refer to the section titled Non-IFRS Financial Measures in this news release. |
(iii) | Maple Leaf defines investment grade leverage as typically operating below 3.0x Net Debt to Trailing Twelve Months Adjusted EBITDA. |
The Company currently expects relatively normal pork market conditions and a stable consumer environment to continue for the balance of the year which is reflected in its increased full year 2025 Adjusted EBITDA outlook. However, evolving macro-economic factors continue to influence the operating environment. These factors may have an impact on consumer sentiment, supply chain activity, access to markets, barriers to trade, markets and foreign exchange rates. The Company leverages its data-driven insights to stay close to these evolving circumstances and is confident in the resilience of its brands, business model and strategy to manage through prevailing economic conditions. At the same time, it recognizes that its ability to deliver its 2025 guidance could be impacted by these conditions, including the impact of tariffs between Canada and the U.S. The Company is continuing to closely monitor the evolving tariff landscape so that it is prepared to adapt quickly as circumstances change. It has already adapted to changes in consumer sentiment that have emerged, including launching brand campaigns in Canada that respond to the "buy Canadian" movement.
Financial Highlights
As part of the restructuring of its commercial and supply chain operations during 2024, the Company split its prepared foods operations into two operating units; Prepared Foods which encompasses its prepared meats and plant protein categories, and Poultry which encompasses its fresh poultry category. Maple Leaf Foods consists of three operating units: Prepared Foods, Poultry, and Pork which represent approximately 55%, 20%, and 25% of total Company revenue respectively.
As at or for the | As at or for the | |||||||||||
($ millions except earnings per share) (Unaudited) | three months ended June 30, | six months ended June 30, | ||||||||||
2025 | 2024 | Change | 2025 | 2024 | Change | |||||||
Sales (i) | $ 1,362.1 | $ 1,255.2 | 8.5 % | $ 2,603.4 | $ 2,402.5 | 8.4 % | ||||||
Gross profit | $ 235.7 | $ 131.2 | 79.6 % | $ 453.5 | $ 357.5 | 26.9 % | ||||||
Selling, general and administrative expenses | $ 113.0 | $ 116.6 | (3.1) % | $ 227.8 | $ 226.7 | 0.5 % | ||||||
Earnings (Loss) | $ 57.8 | $ (26.2) | nm (iii) | $ 107.3 | $ 25.4 | nm (iii) | ||||||
Basic Earnings (Loss) per Share | $ 0.47 | $ (0.21) | nm (iii) | $ 0.87 | $ 0.21 | nm (iii) | ||||||
Adjusted Operating Earnings (ii) | $ 122.8 | $ 78.1 | 57.2 % | $ 218.5 | $ 131.1 | 66.7 % | ||||||
Adjusted EBITDA (ii) | $ 181.6 | $ 140.9 | 28.9 % | $ 348.0 | $ 257.3 | 35.3 % | ||||||
Adjusted EBITDA Margin (ii) | 13.3 % | 11.2 % | 210 bps | 13.4 % | 10.7 % | 270 bps | ||||||
Adjusted EBT (ii) | $ 94.5 | $ 34.4 | nm (iii) | $ 169.3 | $ 44.8 | nm (iii) | ||||||
Adjusted Earnings per Share (ii) | $ 0.56 | $ 0.18 | nm (iii) | $ 0.99 | $ 0.22 | nm (iii) | ||||||
Free Cash Flow (ii) | $ 216.0 | $ 27.0 | nm (iii) | $ 202.4 | $ 100.7 | nm (iii) | ||||||
Net Debt (ii) | $ 1,344.2 | $ 1,723.1 | (22.0) % |
(i) | Quarterly amounts for 2024 have been adjusted to eliminate new sales agreements entered into during the year that contained an expectation of repurchase, which had previously been reported as external sales. |
(ii) | Refer to the section titled Non-IFRS Financial Measures in this news release. |
(iii) | Not meaningful. |
Sales for the second quarter of 2025 were $1,362.1 million compared to $1,255.2 million last year, an increase of 8.5%. Prepared Foods sales increased by 7.5% driven by pricing, improved mix, and volume growth. Poultry sales increased by 8.5% driven by improved channel mix tied to retail and foodservice volume growth, and pricing. Pork sales increased by 10.7% due to an increase in the number of hogs processed and higher average hog weights.
Year-to-date sales for 2025 were $2,603.4 million , compared to $2,402.5 million last year, an increase of 8.4%. Prepared Foods sales increased by 7.3% driven by pricing, improved mix, volume growth, and favourable foreign exchange impacts related to US sales. Poultry sales increased by 7.3% driven by improved channel mix tied to retail and foodservice volume growth, and pricing. Pork sales increased by 11.3% due to an increase in the number of hogs processed, higher average hog weights, and favourable foreign exchange impacts.
Gross profit for the second quarter of 2025 increased to $235.7 million (gross margin of 17.3%) compared to $131.2 million (gross margin of 10.4%) last year. The increase in gross profit was driven by an increase in mark-to-market valuation of biological assets and commodity futures contracts, improved pork market conditions, favourable volume and mix impacts in Prepared Foods and Poultry, and operating efficiencies inclusive of benefits from the investments in the London poultry and Bacon Centre of Excellence facilities. These factors were partially offset by increased trade promotions.
Year-to-date gross profit for 2025 was $453.5 million (gross margin of 17.4%) compared to $357.5 million (gross margin of 14.9%) last year. The increase in gross profit was driven by improved pork market conditions, favourable volume and mix impacts in Prepared Foods and Poultry, and lower start-up expenses. These factors were partially offset by increased trade promotions and a decrease in mark-to-market valuation of biological assets.
Selling, General and Administrative ("SG&A") expenses for the second quarter of 2025 were $113.0 million compared to $116.6 million last year. The decrease in SG&A expenses was primarily driven by lower consulting fees, which were partially offset by higher variable compensation.
Year-to-date SG&A expenses for 2025 were $227.8 million compared to $226.7 million last year. The increase in SG&A expenses was driven by higher variable compensation and higher advertising and promotional expenses, which were partially offset by lower consulting fees.
Earnings for the second quarter of 2025 were $57.8 million ( $0.47 basic earnings per share) compared to a loss of $26.2 million ( $0.21 basic loss per share) last year. Earnings were impacted by the same factors as noted above for gross profit and SG&A as well as reduced interest expense due to lower debt, all partly offset by higher income tax expense as well as incremental costs associated with the upcoming spin-off of the Pork Operations and certain costs associated with the "Fuel for Growth" initiative, both of which were recorded outside of Adjusted Operating Earnings.
Year-to-date earnings for 2025 were $107.3 million ( $0.87 basic earnings per share) compared to $25.4 million ( $0.21 basic earnings per share) last year. Year-to-date earnings were impacted by the same factors as noted above for gross profit and SG&A, as well as reduced interest expense due to lower debt, all partly offset income tax expenses and by incremental costs associated with the upcoming spin-off of the Pork Operations and the "Fuel for Growth" initiative, both of which were recorded outside of Adjusted Operating Earnings.
Adjusted Operating Earnings for the second quarter of 2025 were $122.8 million compared to $78.1 million last year, and Adjusted Earnings per Share for the second quarter of 2025 was $0.56 compared to $0.18 last year. The increase was driven by factors consistent with those noted above for gross profit and SG&A expenses, excluding the impact of unrealized mark-to-market valuation adjustments.
Year-to-date Adjusted Operating Earnings for 2025 were $218.5 million compared to $131.1 million last year, and Adjusted Earnings per Share for 2025 was $0.99 compared to $0.22 last year due to factors consistent with those noted above for gross profit and SG&A expenses excluding the impact of unrealized mark-to-market valuation adjustments and start-up expenses.
Adjusted EBITDA for the second quarter was $181.6 million , compared to $140.9 million last year, driven by factors consistent with those noted above for Adjusted Operating Earnings. Adjusted EBITDA Margin was 13.3% compared to 11.2% last year, also driven by factors consistent with those noted above.
Year-to-date Adjusted EBITDA for 2025 was $348.0 million compared to $257.3 million last year, driven by factors consistent with those noted above for Adjusted Operating Earnings along with reduction of other expense. Year-to-date Adjusted EBITDA Margin for 2025 was 13.4% compared to 10.7% last year, also driven by factors consistent with those noted above.
Adjusted Earnings Before Taxes ("Adjusted EBT") for the second quarter of 2025 were $94.5 million compared to $34.4 million last year due to similar factors as noted above for Adjusted EBITDA, along with a reduction in interest expense.
Year-to-date Adjusted EBT for 2025 were $169.3 million compared to $44.8 million last year due to similar factors as noted above for the second quarter.
Free Cash Flow for the second quarter of 2025 was $216.0 million compared to Free Cash Flow of $27.0 million in the prior year. The improvement was driven by improved earnings after the removal of non-cash items, and timing impacts related to the change in non-cash working capital.
Year-to-date Free Cash Flow for 2025 was $202.4 million compared to Free Cash Flow of $100.7 million in the prior year. Free Cash Flow increased significantly due to improved earnings after the removal of non-cash items, timing impacts related to the change in non-cash working capital, and lower interest payments.
Net Debt as at June 30, 2025 was $1,344.2 million , a decrease of $378.8 million compared to the prior year.
Note: Several items are excluded from the discussions of underlying earnings performance as they are not representative of ongoing operational activities. Refer to the section entitled Non-IFRS Financial Measures at the end of this news release for a description and reconciliation of all non-IFRS financial measures. |
Other Matters
On August 6, 2025 , the Board of Directors approved a quarterly dividend of $0.24 per share, $0.96 per share on an annual basis, payable September 29, 2025 , to shareholders of record at the close of business on September 5, 2025 . Unless indicated otherwise by the Company at or before the time the dividend is paid, the dividend will be considered an eligible dividend for the purposes of the "Enhanced Dividend Tax Credit System". The Company's Dividend Reinvestment Plan ("DRIP") permits eligible shareholders to direct their cash dividends to be reinvested in additional common shares of the Company. The Company eliminated the 2% discount on the treasury shares issued under the DRIP beginning in 2025. Therefore, for shareholders who wish to reinvest their dividends under the DRIP, Maple Leaf Foods intends to issue common shares from treasury at a price equal to 100% of the weighted average closing price of the shares for the five trading days preceding the dividend payment date. Full details of the DRIP, including how to enroll in the program, are available at https://www.mapleleaffoods.com/ .
Conference Call
A conference call will be held at 8:30 a.m. ET on August 7, 2025, to review Maple Leaf Foods' second quarter financial results. To participate in the call, please dial 416-945-7677 or 1-888-699-1199. For those unable to participate, playback will be made available an hour after the event at 289-819-1450 or 1-888-660-6345 (Passcode: 00409#).
A webcast of the second quarter conference call will also be available at: https://www.mapleleaffoods.com/investors/events-and-presentations/ .
The Company's full unaudited condensed consolidated interim financial statements ("Consolidated Interim Financial Statements") and related Management's Discussion and Analysis are available on the Company's website and on SEDAR+ at www.sedarplus.ca .
An investor presentation related to the Company's second quarter financial results is available at www.mapleleaffoods.com under Presentations and Webcasts on the Investors page.
Non-IFRS Financial Measures
The Company uses the following non-IFRS measures: Adjusted Operating Earnings, Adjusted Earnings per Share, Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted EBT, Construction Capital, Net Debt, Net Debt to Trailing Twelve Months Adjusted EBITDA, Free Cash Flow and Return on Net Assets. Management believes that these non-IFRS measures provide useful information to investors in measuring the financial performance of the Company for the reasons outlined below. These measures do not have a standardized meaning prescribed by IFRS and therefore they may not be comparable to similarly titled measures presented by other publicly traded companies and should not be construed as an alternative to other financial measures determined in accordance with IFRS.
Adjusted Operating Earnings, Adjusted EBITDA, Adjusted EBITDA Margin and Adjusted EBT
Adjusted Operating Earnings, Adjusted EBITDA, Adjusted EBITDA Margin and Adjusted EBT are non-IFRS measures used by Management to evaluate financial operating results. Adjusted Operating Earnings is defined as earnings before income taxes adjusted for items that are not considered representative of ongoing operational activities of the business and certain items where the economic impact of the transactions will be reflected in earnings in future periods when the underlying asset is sold or transferred. Adjusted EBITDA is defined as Adjusted Operating Earnings plus depreciation and intangible asset amortization, adjusted for items included in other expense that are considered representative of ongoing operational activities of the business. Adjusted EBITDA Margin is calculated as Adjusted EBITDA divided by sales. Adjusted EBT is used annually by the Company to evaluate its performance and is a component of calculating bonus entitlements under the Company's short term incentive plan. It is defined as Adjusted EBITDA plus interest income, less depreciation and amortization, and interest expense and other financing costs.
The table below provides a reconciliation of earnings before income taxes as reported under IFRS in the Consolidated Interim Financial Statements to Adjusted Operating Earnings, Adjusted EBITDA and Adjusted EBT for the three and six months ended June 30, 2025 as indicated below. Management believes that these non-IFRS measures are useful in assessing the performance of the Company's ongoing operations and its ability to generate cash flows to fund its requirements.
Three months ended June 30, | Six months ended June 30, | |||
($ millions) (i) | 2025 | 2024 | 2025 | 2024 |
Earnings (loss) before income taxes | $ 81.0 | $ (32.5) | $ 151.6 | $ 41.3 |
Interest expense and other financing costs | 26.2 | 43.6 | 55.9 | 85.7 |
Other expense (income) | 12.8 | (3.5) | 14.0 | (2.3) |
Restructuring and other related costs | 2.7 | 6.9 | 4.2 | 6.2 |
Earnings from operations | $ 122.8 | $ 14.5 | $ 225.7 | $ 130.8 |
Start-up expenses from Construction Capital (ii) | 0.8 | 4.4 | 2.2 | 15.8 |
Decrease (increase) in fair value of biological assets | 8.1 | 52.5 | (8.3) | (16.7) |
Decrease (increase) in derivative contracts | (8.9) | 6.8 | (1.0) | 1.1 |
Adjusted Operating Earnings | $ 122.8 | $ 78.1 | $ 218.5 | $ 131.1 |
Depreciation and amortization (iii) | 61.5 | 63.7 | 124.1 | 128.6 |
Items included in other income (expense) representative of | (2.7) | (0.9) | 5.3 | (2.4) |
Adjusted EBITDA | $ 181.6 | $ 140.9 | $ 348.0 | $ 257.3 |
Adjusted EBITDA Margin (v) | 13.3 % | 11.2 % | 13.4 % | 10.7 % |
Interest expense and other financing costs | (26.2) | (43.6) | (55.9) | (85.7) |
Interest income | 0.6 | 0.8 | 1.3 | 1.8 |
Depreciation and amortization | (61.5) | (63.7) | (124.1) | (128.6) |
Adjusted EBT | $ 94.5 | $ 34.4 | $ 169.3 | $ 44.8 |
(i) | Totals may not add due to rounding. |
(ii) | Start-up expenses are temporary costs as a result of operating new facilities that are or were previously classified as Construction Capital. These costs can include training, product testing, yield and labour efficiency variances, duplicative overheads including depreciation and other temporary expenses required to ramp-up production. |
(iii) | Depreciation included in start-up expenses is excluded from this line. |
(iv) | Primarily includes certain costs associated with sustainability projects, gains and losses on the impairment and sale of long-term assets, gains and losses on investments and other miscellaneous expenses. |
(v) | Quarterly amounts for 2024 have been adjusted to eliminate new sales agreements entered into during the year that contained an expectation of repurchase, which had previously been reported as external sales. |
Adjusted Earnings per Share
Adjusted Earnings per Share, a non-IFRS measure, is used by Management to evaluate financial operating results. It is defined as basic earnings per share and is adjusted on the same basis as Adjusted Operating Earnings. The table below provides a reconciliation of basic earnings per share as reported under IFRS in the Consolidated Interim Financial Statements to Adjusted Earnings per Share for the three and six months ended June 30 as indicated below. Management believes this basis is the most appropriate on which to evaluate financial results as they are representative of the ongoing operations of the Company.
($ per share) (Unaudited) | Three months ended June 30, | Six months ended June 30, | ||||||
2025 | 2024 | 2025 | 2024 | |||||
Basic earnings (loss) per share | $ 0.47 | $ (0.21) | $ 0.87 | $ 0.21 | ||||
Restructuring and other related costs (i) | 0.02 | 0.04 | 0.03 | 0.04 | ||||
Items included in other expense not considered | 0.07 | (0.03) | 0.14 | (0.02) | ||||
Start-up expenses from Construction Capital (iii) | 0.01 | 0.03 | 0.01 | 0.10 | ||||
Change in fair value of biological assets | 0.05 | 0.31 | (0.05) | (0.12) | ||||
Change in unrealized and deferred fair value on derivatives | (0.05) | 0.04 | (0.01) | 0.01 | ||||
Adjusted Earnings per Share(iv) | $ 0.56 | $ 0.18 | $ 0.99 | $ 0.22 |
(i) | Includes per share impact of restructuring and other related costs, net of tax. |
(ii) | Primarily includes legal fees, vacancy costs on investment property, transaction related costs and costs associated with "Fuel for Growth", net of tax. |
(iii) | Start-up expenses are temporary costs as a result of operating new facilities that are or were previously classified as Construction Capital. These costs can include training, product testing, yield and labour efficiency variances, duplicative overheads and other temporary expenses required to ramp-up production, net of tax. |
(iv) | Totals may not add due to rounding. |
Construction Capital
Construction Capital, a non-IFRS measure, is used by Management to evaluate the amount of capital resources invested in specific strategic development projects that are not yet operational. It is defined as investments and related financing charges in projects over $50 million that are related to longer-term strategic initiatives, with no returns expected for at least 12 months from commencement of construction and the asset is re-categorized from Construction Capital once operational. There were no Construction Capital projects during the three and six months ended June 30, 2025 or June 30, 2024 as all projects had been completed and recategorized as regular property and equipment.
Net Debt
The following table reconciles Net Debt and Net Debt to Trailing Twelve Months Adjusted EBITDA ratio to amounts reported under IFRS in the Company's Consolidated Interim Financial Statements as at June 30 as indicated below. The Company calculates Net Debt as cash and cash equivalents, less current and long-term debt and bank indebtedness and calculates Net Debt to Trailing Twelve Months Adjusted EBITDA as the absolute value of Net Debt divided by Trailing Twelve Months Adjusted EBITDA. Management believes this measure is useful in assessing the amount of financial leverage employed.
($ thousands) (Unaudited) | As at June 30, | ||||||
2025 | 2024 | ||||||
Cash and cash equivalents | $ 236,045 | $ 158,381 | |||||
Current portion of long-term debt | $ (351,673) | $ (300,371) | |||||
Long-term debt | (1,228,599) | (1,581,093) | |||||
Total debt | $(1,580,272) | $(1,881,464) | |||||
Net Debt | $(1,344,227) | $(1,723,083) | |||||
Trailing Twelve Months Adjusted EBITDA (i) | $ 643,865 | $ 506,468 | |||||
Net Debt to Trailing Twelve Months Adjusted EBITDA | 2.1 | 3.4 | |||||
(i) | Trailing Twelve Months includes Q3 2024, Q4 2024, Q1 2025, and Q2 2025 for 2025; and Q3 2023, Q4 2023, Q1 2024, and Q2 2024 for 2024. |
Free Cash Flow
Free Cash Flow, a non-IFRS measure, is used by Management to evaluate cash flow after investing in the maintenance of the Company's asset base. It is defined as cash provided by operations, less Maintenance Capital (i) and associated interest paid and capitalized. The following table calculates Free Cash Flow for the periods indicated below:
($ thousands) (Unaudited) | Three months ended June 30, | Six months ended June 30, | ||||||
2025 | 2024 | 2025 | 2024 | |||||
Cash provided by operating activities | $ 239,587 | $ 45,496 | $ 249,470 | $ 132,821 | ||||
Maintenance Capital (i) | (23,276) | (18,250) | (46,516) | (31,686) | ||||
Interest paid and capitalized related to | (285) | (220) | (555) | (483) | ||||
Free Cash Flow | $ 216,026 | $ 27,026 | $ 202,399 | $ 100,652 |
(i) | Maintenance Capital is defined as non-discretionary investment required to maintain the Company's existing operations and competitive position. For the three and six months ended June 30, 2025, total capital spending of $24.4 millionand $49.3 million (2024: $16.3 million and $40.1 million) shown on the Consolidated Interim Statements of Cash Flows is made up of Maintenance Capital of $23.3 million and $46.5 million (2024: $18.3 million and $31.7 million), and Growth Capital of $1.1 million for the three months ended June 30, 2025 and $2.8 million for the six months ended June 30, 2025 (2024: net inflow of $2.0 million as a result of government grants received and a net outflow of $8.4 million). Growth Capital is defined as discretionary investment meant to create stakeholder value through initiatives that for example, expand margins, increase capacities or create further competitive advantage. |
Return on Net Assets ("RONA")
RONA is calculated by dividing tax effected earnings from operations (adjusted for items which are not considered representative of the underlying operations of the business) by average monthly net assets. Net assets are defined as total assets (excluding cash and deferred tax assets) less non-interest bearing liabilities (excluding deferred tax liabilities). Management believes that RONA is an appropriate basis upon which to evaluate long-term financial performance.
Forward-Looking Statements
This document contains, and the Company's oral and written public communications often contain, "forward-looking information" within the meaning of applicable securities law. These statements are based on current expectations, estimates, projections, beliefs, judgements and assumptions based on information available at the time the applicable forward-looking statement was made and in light of the Company's experience combined with its perception of historical trends. Such statements include, but are not limited to, statements with respect to objectives and goals, in addition to statements with respect to beliefs, plans, targets, goals, objectives, expectations, anticipations, estimates, and intentions. Forward-looking statements are typically identified by words such as "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "could", "would", "believe", "plan", "intend", "design", "target", "undertake", "view", "indicate", "maintain", "explore", "entail", "schedule", "objective", "strategy", "likely", "potential", "outlook", "aim", "propose", "goal", and similar expressions suggesting future events or future performance. These statements are not guarantees of future performance and involve assumptions, risks and uncertainties that are difficult to predict.
By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. The Company believes the expectations reflected in the forward-looking statements are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward-looking statements should not be unduly relied upon.
Specific forward-looking information in this document may include, but is not limited to, statements with respect to:
Various factors or assumptions are typically applied by the Company in drawing conclusions or making the forecasts, projections, predictions or estimations set out in the forward-looking statements. These factors and assumptions are based on information currently available to the Company, including information obtained by the Company from third-party sources and include but are not limited to the following:
Readers are cautioned that these assumptions may prove to be incorrect in whole or in part. The Company's actual results may differ materially from those anticipated in any forward-looking statements.
Factors that could cause actual results or outcomes to differ materially from the results expressed, implied, or projected in the forward-looking statements contained in this document include, among other things, risks associated with the following:
The Company cautions readers that the foregoing list of factors is not exhaustive.
Readers are further cautioned that some of the forward-looking information, such as statements concerning future capital expenditures, Adjusted EBITDA expectations, Adjusted EBITDA Margin expansion, and the Company's ability to achieve its financial targets or projections may be considered to be financial outlooks for purposes of applicable securities legislation. These financial outlooks are presented to evaluate potential future earnings and anticipated future uses of cash flows and may not be appropriate for other purposes. Readers should not assume these financial outlooks will be achieved.
More information about risk factors can be found under the heading "Risk Factors" in the Company's Annual Management's Discussion and Analysis for the year ended December 31, 2024 , that is available on SEDAR+ at www.sedarplus.ca . The reader should review such section in detail. Additional information concerning the Company, including the Company's Annual Information Form, is available on SEDAR+ at www.sedarplus.ca .
All forward-looking statements included herein speak only as of the date hereof. Unless required by law, the Company does not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. All forward-looking statements contained herein are expressly qualified by this cautionary statement.
Management's Estimates on the Pork Operations spin-off, and related Non-IFRS measures
The following tables present Management's preliminary estimates of certain financial information regarding Canada Packers and the business that will be retained after the separation by Maple Leaf Foods. These preliminary estimates have not been audited or reviewed by any third party, have been derived from internal management reporting, and reflect sales, cost and expense allocations, including with respect to corporate expenses, as well as other estimates and adjustments, each of which is preliminary in nature and subject to change.
Management believes that these preliminary estimates are useful in providing an indication of the relative size of the businesses upon separation. These preliminary estimates continue to be refined as the Company works to finalize the separation.
Quarter ended June 30, 2025 | ||||||||
(in millions of Canadian dollars) (unaudited) | Canada | Maple Leaf | Eliminations | Consolidated | ||||
Sales (IFRS) | $ 473 | (ii) | $ 1,001 | (iii) | $ (112) | (iv) | $ 1,362 | (v) |
Estimate of potential impact of separation (vi) | (17) | 18 | ||||||
Pro Forma Sales | $ 456 | $ 1,019 | ||||||
Adjusted EBITDA | $ 52 | (vii) | $ 130 | (viii) | — | $ 182 | (v),(ix) | |
Adjusted EBITDA Margin * | 11.0 % | 13.0 % | — % | 13.3 % | ||||
Estimate of potential impact of separation (xi) | ~$(7) | ~$5 | ||||||
Pro Forma Adjusted EBITDA (xii) | ~$45 | ~$134 | ||||||
Pro Forma Adjusted EBITDA margin (xiii) | ~10% | ~13% | ||||||
Estimate of potential market normalization impact (xiv) | ~$3 - 6 | |||||||
Pro Forma normalized Adjusted EBITDA (xv) | ~$50 | |||||||
Pro Forma normalized Adjusted EBITDA Margin (xvi) | ~11% |
Notes | |
(i) | Refers to the business that will be retained after the separation by Maple Leaf Foods Inc. |
(ii) | Represents management's preliminary estimate of sales (both to Maple Leaf Foods and to external third parties) attributable to the business that will be transferred to Canada Packers in the separation for the period presented. |
(iii) | Represents management's preliminary estimate of sales attributable to the business that will be retained by Maple Leaf Foods after the separation for the period presented. |
(iv) | Primarily represents management's preliminary estimate of sales from Canada Packers to Maple Leaf Foods for the period presented. |
(v) | See the Company's Q2 2025 Consolidated Interim Financial Statements filed on SEDAR+ |
(vi) | Represents management's preliminary estimate of the potential impact on Sales of Canada Packers and Maple Leaf Foods (as defined in note (i) above), respectively, if the separation had occurred on April 1, 2025. Primarily relates to management's preliminary estimate of the change in sales as a result of the anticipated impact of the supply agreement and other contractual arrangements expected to be entered into in connection with the separation. |
(vii) | Represents management's preliminary estimate of the portion of consolidated Adjusted EBITDA attributable to Canada Packers for the period presented. As noted above, this estimate is subject to change as the Company works to finalize the separation. |
(viii) | Represents management's preliminary estimate of the portion of consolidated Adjusted EBITDA attributable to Maple Leaf Foods (as defined in note (i) above) for the period presented. As noted above, this estimate is subject to change as the Company works to finalize the separation. |
(ix) | For a definition of Adjusted EBITDA (consolidated), and a reconciliation of Adjusted EBITDA (consolidated) for the periods described in note (v) above to consolidated net income for such periods, see the Company's MD&A filed on SEDAR+ for the quarter ended June 30, 2025. |
* | Defined as Adjusted EBITDA divided by Sales. This metric is subject to change as the Company works to finalize the separation in the same manner as the metrics from which this metric is derived, as noted above. |
(xi) | Represents management's preliminary estimate of the potential impact on Adjusted EBITDA of Canada Packers and Maple Leaf Foods (as defined in note (i) above), respectively, if the separation had occurred on April 1, 2025. Primarily relates to management's preliminary estimate of (1) a change in Adjusted EBITDA of Canada Packers and an offsetting change in Adjusted EBITDA of Maple Leaf Foods as a result of the anticipated impact of the supply agreement and other contractual arrangements expected to be entered into in connection with the separation, (2) public company costs that would have been incurred by Canada Packers, and (3) a reallocation of certain SG&A expenses between Canada Packers and Maple Leaf Foods. As noted above, this estimate is subject to change and is expected to be refined prior to the separation. |
(xii) | Defined as Adjusted EBITDA plus management's preliminary estimate of the potential impact of the separation described in, and subject to the qualifications described in, note (xi) above. |
(xiii) | Defined as Pro Forma Adjusted EBITDA, as described in note (xii) above divided by Pro Forma Sales. This metric is subject to change as the Company works to finalize the separation in the same manner as the metrics from which this metric is derived, as noted above. |
(xiv) | Presented for illustrative purposes only, based on management estimates and assumptions, to indicate what the potential impact on Pro Forma Adjusted EBITDA may have been if market conditions during the period presented had reflected normal market conditions, defined as the 5-year pre-pandemic (2015 – 2019) average ("Normal Market Conditions"). Actual market conditions during the period presented were materially different from Normal Market Conditions, and there can be no assurance that actual Pro Forma Adjusted EBITDA would have been impacted in the manner shown if Normal Market Conditions had existed during the period presented, or that actual future market conditions will reflect Normal Market Conditions. This metric is not intended to be indicative of potential financial results for any future period. |
(xv) | Defined as Pro Forma Adjusted EBITDA, as described in note (xi) above, plus management's preliminary estimate of the potential impact if market conditions during the period presented had reflected Normal Market Conditions, subject to the qualifications described in note (xiv) above. This metric is presented for illustrative purposes only and is not intended to be indicative of potential financial results for any future period. |
(xvi) | Defined as Pro Forma normalized Adjusted EBITDA, as described in note (xiv) above, divided by Pro Forma Sales. This metric is presented for illustrative purposes only and is based on management estimates and assumptions. This metric is subject to change and is expected to be refined prior to the separation in the same manner as the metrics from which this metric is derived, as noted above. Actual market conditions during the period presented were materially different from Normal Market Conditions, and there can be no assurance that actual Pro Forma Adjusted EBITDA Margin would have been impacted in the manner shown if Normal Market Conditions had existed during the period presented, or that actual future market conditions will reflect Normal Market Conditions. This metric is not intended to be indicative of potential financial results for any future period. |
Last twelve months ended June 30, 2025 | ||||||||
(in millions of Canadian dollars) (unaudited) | Canada | Maple Leaf | Eliminations | Consolidated | ||||
Sales (IFRS) | $ 1,769 | (ii) | $ 3,751 | (iii) | $ (424) | (iv) | $ 5,096 | (v) |
Estimate of potential impact of separation (vi) | (77) | 71 | ||||||
Pro Forma Sales | $ 1,692 | $ 3,822 | ||||||
Adjusted EBITDA | $ 192 | (vii) | $ 452 | (viii) | — | $ 644 | (v),(ix) | |
Adjusted EBITDA Margin * | 10.9 % | 12.1 % | — % | 12.6 % | ||||
Estimate of potential impact of separation (xi) | ~$(21) | ~11 | ||||||
Pro Forma Adjusted EBITDA (xii) | ~$170 | ~$463 | ||||||
Pro Forma Adjusted EBITDA margin (xiii) | ~10% | ~12% | ||||||
Estimate of potential market normalization impact (xiv) | ~$30 - 40 | |||||||
Pro Forma normalized Adjusted EBITDA (xv) | ~$200 | |||||||
Pro Forma normalized Adjusted EBITDA Margin (xvi) | ~12% |
Notes | |
(i) | Refers to the business that will be retained after the separation by Maple Leaf Foods Inc. |
(ii) | Represents management's preliminary estimate of sales (both to Maple Leaf Foods and to external third parties) attributable to the business that will be transferred to Canada Packers in the separation for the period presented. |
(iii) | Represents management's preliminary estimate of sales attributable to the business that will be retained by Maple Leaf Foods after the separation for the period presented. |
(iv) | Primarily represents management's preliminary estimate of sales from Canada Packers to Maple Leaf Foods for the period presented. |
(v) | Calculated by adding the previously reported results for the year ended December 31, 2024 to results for the six months ended June 30, 2025 and subtracting results for the six months ended June 30, 2024. These results are reported in the Company's MD&A filed on SEDAR and SEDAR+ for the year ended December 31, 2024, the quarter ended June 30, 2025 and the quarter ended June 30, 2024. |
(vi) | Represents management's preliminary estimate of the potential impact on Sales of Canada Packers and Maple Leaf Foods (as defined in note (i) above), respectively, if the separation had occurred on June 30, 2024. Primarily relates to management's preliminary estimate of the change in sales as a result of the anticipated impact of the supply agreement and other contractual arrangements expected to be entered into in connection with the separation. |
(vii) | Represents management's preliminary estimate of the portion of consolidated Adjusted EBITDA attributable to Canada Packers for the period presented. As noted above, this estimate is subject to change as the Company works to finalize the separation. |
(viii) | Represents management's preliminary estimate of the portion of consolidated Adjusted EBITDA attributable to Maple Leaf Foods (as defined in note (i) above) for the period presented. As noted above, this estimate is subject to change as the Company works to finalize the separation. |
(ix) | For a definition of Adjusted EBITDA (consolidated), and a reconciliation of Adjusted EBITDA (consolidated) for the periods described in note (v) above to consolidated net income for such periods, see the Company's MD&A filed on SEDAR and SEDAR+ for the year ended December 31, 2024, the quarter ended June 30, 2025 and the quarter ended June 30, 2024. |
* | Defined as Adjusted EBITDA divided by Sales. This metric is subject to change as the Company works to finalize the separation in the same manner as the metrics from which this metric is derived, as noted above. |
(xi) | Represents management's preliminary estimate of the potential impact on Adjusted EBITDA of Canada Packers and Maple Leaf Foods (as defined in note (i) above), respectively, if the separation had occurred on June 30, 2024. Primarily relates to management's preliminary estimate of (1) a change in Adjusted EBITDA of Canada Packers and an offsetting change in Adjusted EBITDA of Maple Leaf Foods as a result of the anticipated impact of the supply agreement and other contractual arrangements expected to be entered into in connection with the separation, (2) public company costs that would have been incurred by Canada Packers, and (3) a reallocation of certain SG&A expenses between Canada Packers and Maple Leaf Foods. As noted above, this estimate is subject to change as the Company works to finalize the separation. |
(xii) | Defined as Adjusted EBITDA plus management's preliminary estimate of the potential impact of the separation described in, and subject to the qualifications described in, note (xi) above. |
(xiii) | Defined as Pro Forma Adjusted EBITDA, as described in note (xii) above divided by Pro Forma Sales. This metric is subject to change as the Company works to finalize the separation in the same manner as the metrics from which this metric is derived, as noted above. |
(xiv) | Presented for illustrative purposes only, based on management estimates and assumptions, to indicate what the potential impact on Pro Forma Adjusted EBITDA may have been if market conditions during the period presented had reflected normal market conditions, defined as the 5-year pre-pandemic (2015 – 2019) average ("Normal Market Conditions"). Actual market conditions during the period presented were materially different from Normal Market Conditions, and there can be no assurance that actual Pro Forma Adjusted EBITDA would have been impacted in the manner shown if Normal Market Conditions had existed during the period presented, or that actual future market conditions will reflect Normal Market Conditions. This metric is not intended to be indicative of potential financial results for any future period. |
(xv) | Defined as Pro Forma Adjusted EBITDA, as described in note (xi) above, plus management's preliminary estimate of the potential impact if market conditions during the period presented had reflected Normal Market Conditions, subject to the qualifications described in note (xiv) above. This metric is presented for illustrative purposes only and is not intended to be indicative of potential financial results for any future period. |
(xvi) | Defined as Pro Forma normalized Adjusted EBITDA, as described in note (xiv) above, divided by Pro Forma Sales.This metric is presented for illustrative purposes only and is based on management estimates and assumptions. This metric is subject to change and is expected to be refined prior to the separation in the same manner as the metrics from which this metric is derived, as noted above. Actual market conditions during the period presented were materially different from Normal Market Conditions, and there can be no assurance that actual Pro Forma Adjusted EBITDA Margin would have been impacted in the manner shown if Normal Market Conditions had existed during the period presented, or that actual future market conditions will reflect Normal Market Conditions. This metric is not intended to be indicative of potential financial results for any future period. |
Adjusted EBITDA, Pro Forma Adjusted EBITDA, and Pro Forma normalized Adjusted EBITDA, and related margins, as presented in the tables above, are non-IFRS metrics and do not have a standardized meaning prescribed by IFRS. Consequently, they may not be comparable to similarly titled measures presented by other publicly traded companies and should not be construed as an alternative to other financial measures determined in accordance with IFRS.
About Maple Leaf Foods Inc.
Maple Leaf Foods is a leading protein company responsibly producing food products under leading brands including Maple Leaf ® , Maple Leaf Prime ® , Maple Leaf Natural Selections ® , Schneiders ® , Mina ® , Greenfield Natural Meat Co. ® , Lightlife ® and Field Roast™. The Company's portfolio includes prepared meats, ready-to-cook and ready-to-serve meals, snack kits, value-added fresh pork and poultry, and plant protein products. The Company employs approximately 13,500 people and does business primarily in Canada , the U.S. and Asia . The Company is headquartered in Mississauga, Ontario and its shares trade on the Toronto Stock Exchange (MFI).
Consolidated Interim Balance Sheets
(In thousands of Canadian dollars) | As at June 30, | As at June 30, 2024 | As at December 31, | |||
ASSETS | ||||||
Cash and cash equivalents | $ 236,045 | $ 158,381 | $ 175,908 | |||
Accounts receivable | 175,559 | 184,300 | 170,919 | |||
Notes receivable | 45,510 | 44,886 | 37,978 | |||
Inventories | 602,370 | 580,472 | 553,398 | |||
Biological assets | 175,550 | 124,688 | 169,399 | |||
Income and other taxes recoverable | 2,474 | 62,761 | 7,551 | |||
Prepaid expenses and other assets | 39,155 | 35,203 | 42,342 | |||
Assets held for sale | — | 27,438 | 22,769 | |||
Total current assets | $ 1,276,663 | $ 1,218,129 | $ 1,180,264 | |||
Property and equipment | 2,058,069 | 2,186,520 | 2,123,167 | |||
Right-of-use assets | 149,272 | 171,692 | 160,922 | |||
Investments | 12,500 | 16,112 | 12,763 | |||
Investment property | 63,488 | 34,744 | 42,588 | |||
Employee benefits | 15,500 | 116,800 | 22,429 | |||
Other long-term assets | 23,624 | 22,271 | 24,918 | |||
Deferred tax asset | 45,808 | 42,504 | 46,588 | |||
Goodwill | 477,353 | 477,353 | 477,353 | |||
Intangible assets | 325,055 | 343,457 | 339,526 | |||
Total long-term assets | $ 3,170,669 | $ 3,411,453 | $ 3,250,254 | |||
Total assets | $ 4,447,332 | $ 4,629,582 | $ 4,430,518 | |||
LIABILITIES AND EQUITY | ||||||
Accounts payable and accruals | $ 628,257 | $ 543,792 | $ 561,179 | |||
Current portion of provisions | 9,182 | 9,673 | 14,482 | |||
Current portion of long-term debt | 351,673 | 300,371 | 301,478 | |||
Current portion of lease obligations | 39,710 | 40,544 | 39,900 | |||
Income taxes payable | 51,955 | 2,351 | 2,595 | |||
Other current liabilities | 29,342 | 24,986 | 37,587 | |||
Total current liabilities | $ 1,110,119 | $ 921,717 | $ 957,221 | |||
Long-term debt | 1,228,599 | 1,581,093 | 1,390,479 | |||
Lease obligations | 136,631 | 157,550 | 147,892 | |||
Employee benefits | 61,837 | 60,796 | 62,395 | |||
Provisions | 3,122 | 1,998 | 3,912 | |||
Other long-term liabilities | 4,961 | 1,167 | 5,205 | |||
Deferred tax liability | 313,939 | 330,232 | 325,137 | |||
Total long-term liabilities | $ 1,749,089 | $ 2,132,836 | $ 1,935,020 | |||
Total liabilities | $ 2,859,208 | $ 3,054,553 | $ 2,892,241 | |||
Shareholders' equity | ||||||
Share capital | $ 904,226 | $ 886,876 | $ 897,839 | |||
Retained earnings | 631,839 | 640,589 | 587,393 | |||
Contributed surplus | 14,049 | 6,773 | 12,482 | |||
Accumulated other comprehensive income | 38,642 | 44,222 | 43,994 | |||
Treasury shares | (632) | (3,431) | (3,431) | |||
Total shareholders' equity | $ 1,588,124 | $ 1,575,029 | $ 1,538,277 | |||
Total liabilities and equity | $ 4,447,332 | $ 4,629,582 | $ 4,430,518 |
Consolidated Interim Statements of Earnings (Loss)
(In thousands of Canadian dollars, except share amounts) (Unaudited) | Three months ended June 30, | Six months ended June 30, | ||||||
2025 | 2024 (i) | 2025 | 2024 (i) | |||||
Sales | $ 1,362,144 | $ 1,255,173 | $ 2,603,437 | $ 2,402,464 | ||||
Cost of goods sold | 1,126,427 | 1,124,018 | 2,149,946 | 2,044,969 | ||||
Gross profit | $ 235,717 | $ 131,155 | $ 453,491 | $ 357,495 | ||||
Selling, general and administrative expenses | 112,966 | 116,649 | 227,773 | 226,682 | ||||
Earnings before the following: | $ 122,751 | $ 14,506 | $ 225,718 | $ 130,813 | ||||
Restructuring and other related costs | 2,705 | 6,893 | 4,208 | 6,168 | ||||
Other expense (income) | 12,789 | (3,492) | 14,022 | (2,335) | ||||
Earnings before interest and income taxes | $ 107,257 | $ 11,105 | $ 207,488 | $ 126,980 | ||||
Interest expense and other financing costs | 26,234 | 43,637 | 55,880 | 85,720 | ||||
Earnings (loss) before income taxes | $ 81,023 | $ (32,532) | $ 151,608 | $ 41,260 | ||||
Income tax expense (recovery) | 23,245 | (6,359) | 44,267 | 15,882 | ||||
Earnings (loss) | $ 57,778 | $ (26,173) | $ 107,341 | $ 25,378 | ||||
Earnings (loss) per share attributable to common shareholders: | ||||||||
Basic earnings (loss) per share | $ 0.47 | $ (0.21) | $ 0.87 | $ 0.21 | ||||
Diluted earnings (loss) per share | $ 0.46 | $ (0.21) | $ 0.86 | $ 0.20 | ||||
Weighted average number of shares (millions): | ||||||||
Basic | 123.9 | 122.9 | 123.8 | 122.7 | ||||
Diluted | 125.6 | 122.9 | 125.3 | 123.8 |
(i) | Quarterly amounts for 2024 have been adjusted. See Note 16 in the condensed consolidated interim financial statements as filed on SEDAR+ at www.sedarplus.ca. |
Consolidated Interim Statements of Other Comprehensive Income
(In thousands of Canadian dollars) (Unaudited) | Three months ended June 30, | Six months ended June 30, | ||||||
2025 | 2024 | 2025 | 2024 | |||||
Earnings (loss) | $ 57,778 | $ (26,173) | $ 107,341 | $ 25,378 | ||||
Other comprehensive (loss) income | ||||||||
Actuarial gains (losses) that will not be reclassified | $ (7,453) | $ 65,346 | $ (3,319) | $ 71,951 | ||||
Total items that will not be reclassified to profit or loss | $ (7,453) | $ 65,346 | $ (3,319) | $ 71,951 | ||||
Items that are or may be reclassified subsequently to profit or loss: | ||||||||
Change in accumulated foreign currency | (20,338) | 3,401 | (20,365) | 11,111 | ||||
Change in foreign exchange on long-term debt million and $1.8 million) | 15,230 | (3,226) | 15,343 | (9,838) | ||||
Change in cash flow hedges (Net of tax of $0.0 | (76) | (1,258) | (330) | (4,880) | ||||
Total items that are or may be reclassified subsequently to profit or loss | $ (5,184) | $ (1,083) | $ (5,352) | $ (3,607) | ||||
Total other comprehensive (loss) income | $ (12,637) | $ 64,263 | $ (8,671) | $ 68,344 | ||||
Comprehensive income | $ 45,141 | $ 38,090 | $ 98,670 | $ 93,722 |
Consolidated Interim Statements of Changes in Total Equity
Accumulated other comprehensive income (loss) | |||||||||
(In thousands of Canadian dollars) (Unaudited) | Share capital | Retained earnings | Contributed surplus | Foreign | Unrealized | Unrealized | Revaluation | Treasury shares | Total equity |
Balance at December 31, 2024 | $ 897,839 | 587,393 | 12,482 | 14,545 | (1,257) | (6,641) | 37,347 | (3,431) | $ 1,538,277 |
Earnings | — | 107,341 | — | — | — | — | — | — | 107,341 |
Other comprehensive income (loss) (ii) | — | (3,319) | — | (5,022) | (330) | — | — | — | (8,671) |
Dividends declared ($0.48 per share) | 5,695 | (59,576) | — | — | — | — | — | — | (53,881) |
Share-based compensation expense | — | — | 12,406 | — | — | — | — | — | 12,406 |
Deferred taxes on share-based compensation | — | — | 3,175 | — | — | — | — | — | 3,175 |
Exercise of stock options | 692 | — | — | — | — | — | — | — | 692 |
Shares purchased by RSU trust | — | — | — | — | — | — | — | (4,094) | (4,094) |
Settlement of share-based compensation | — | — | (14,014) | — | — | — | — | 6,893 | (7,121) |
Balance at June 30, 2025 | $ 904,226 | 631,839 | 14,049 | 9,523 | (1,587) | (6,641) | 37,347 | (632) | $ 1,588,124 |
Accumulated other comprehensive income (loss) (i) | |||||||||
(In thousands of Canadian dollars) (Unaudited) | Share capital | Retained earnings | Contributed surplus | Foreign | Unrealized | Unrealized value of | Revaluation | Treasury shares | Total equity |
Balance at December 31, 2023 | $ 873,477 | 597,429 | 3,227 | 8,625 | 4,416 | (2,559) | 37,347 | (7,183) | $ 1,514,779 |
Earnings | — | 25,378 | — | — | — | — | — | — | 25,378 |
Other comprehensive income (loss) (ii) | — | 71,951 | — | 1,273 | (4,880) | — | — | — | 68,344 |
Dividends declared ($0.44 per share) | 10,901 | (54,169) | — | — | — | — | — | — | (43,268) |
Share-based compensation expense | — | — | 11,387 | — | — | — | — | — | 11,387 |
Deferred taxes on share-based compensation | — | — | (425) | — | — | — | — | — | (425) |
Exercise of stock options | 2,498 | — | — | — | — | — | — | — | 2,498 |
Settlement of share-based compensation | — | — | (7,416) | — | — | — | — | 3,752 | (3,664) |
Balance at June 30, 2024 | $ 886,876 | 640,589 | 6,773 | 9,898 | (464) | (2,559) | 37,347 | (3,431) | $ 1,575,029 |
(i) | Items that are or may be subsequently reclassified to profit or loss. |
(ii) | Included in other comprehensive income (loss) is the change in actuarial gains and losses that will not be reclassified to profit or loss and has been reclassified to retained earnings. |
Consolidated Interim Statements of Cash Flows
(In thousands of Canadian dollars) (Unaudited) | Three months ended June 30, | Six months ended June 30, | ||||||
2025 | 2024 | 2025 | 2024 | |||||
CASH PROVIDED BY (USED IN): | ||||||||
Operating activities | ||||||||
Earnings (loss) | $ 57,778 | $ (26,173) | $ 107,341 | $ 25,378 | ||||
Add (deduct) items not affecting cash: | ||||||||
Change in fair value of biological assets | 8,087 | 52,488 | (8,324) | (16,655) | ||||
Depreciation and amortization | 62,103 | 64,446 | 125,757 | 130,299 | ||||
Share-based compensation | 6,629 | 6,089 | 12,406 | 11,387 | ||||
Deferred income tax (recovery) expense | (8,237) | (8,843) | (11,954) | 11,093 | ||||
Current income tax expense | 31,482 | 2,484 | 56,221 | 4,789 | ||||
Interest expense and other financing costs | 26,234 | 43,637 | 55,880 | 85,720 | ||||
Gain on sale of long-term assets | — | (1,326) | (10,609) | (1,637) | ||||
Impairment of property and equipment and right-of-use assets | 1,291 | 118 | 2,157 | 118 | ||||
Change in fair value of long-term assets | — | (5,038) | — | (5,038) | ||||
Change in fair value of non-designated derivatives | (744) | 2,991 | 378 | (1,674) | ||||
Change in net pension obligation | 1,233 | 2,169 | 1,952 | 3,236 | ||||
Net income taxes (paid) refunded | (229) | 18,764 | (1,594) | 21,746 | ||||
Interest paid, net of capitalized interest | (26,127) | (32,459) | (54,700) | (72,936) | ||||
Change in provision for restructuring and other related costs | (1,788) | 3,087 | (6,051) | (173) | ||||
Change in derivatives margin | 3,650 | (1,075) | 2,039 | 1,241 | ||||
Cash settlement of derivatives | — | (728) | — | (2,878) | ||||
Other | (23,549) | 2,231 | (18,404) | 5,324 | ||||
Change in non-cash operating working capital | 101,774 | (77,366) | (3,025) | (66,519) | ||||
Cash provided by operating activities | $ 239,587 | $ 45,496 | $ 249,470 | $ 132,821 | ||||
Investing activities | ||||||||
Additions to long-term assets | $ (24,433) | $ (16,318) | $ (49,285) | $ (40,131) | ||||
Interest paid and capitalized | (303) | (219) | (583) | (574) | ||||
Proceeds from sale of long-term assets | 1,750 | 2,631 | 14,754 | 3,496 | ||||
Cash used in investing activities | $ (22,986) | $ (13,906) | $ (35,114) | $ (37,209) | ||||
Financing activities | ||||||||
Dividends paid | $ (27,150) | $ (21,607) | $ (53,881) | $ (43,268) | ||||
Net decrease in long-term debt | (60,265) | (50,480) | (80,047) | (81,365) | ||||
Payment of lease obligation | (8,091) | (7,891) | (16,183) | (16,337) | ||||
Exercise of stock options | 534 | 2,498 | 534 | 2,498 | ||||
Purchase of treasury shares | (4,094) | — | (4,094) | — | ||||
Payment of financing fees | (541) | (2,122) | (548) | (2,122) | ||||
Cash used in financing activities | $ (99,607) | $ (79,602) | $ (154,219) | $ (140,594) | ||||
Increase (decrease) in cash and cash equivalents | $ 116,994 | $ (48,012) | $ 60,137 | $ (44,982) | ||||
Cash and cash equivalents, beginning of period | 119,051 | 206,393 | 175,908 | 203,363 | ||||
Cash and cash equivalents, end of period | $ 236,045 | $ 158,381 | $ 236,045 | $ 158,381 |
SOURCE Maple Leaf Foods Inc.
7 augusti, 11:59
Maple Leaf Foods Reports Second Quarter 2025 Financial Results
PR Newswire
MISSISSAUGA, ON, Aug. 7, 2025
TSX: MFI
Maple Leaf Foods reports Revenue growth of 8.5%, Adjusted EBITDA growth of 28.9%, and increases its fiscal 2025 Adjusted EBITDA outlook
MISSISSAUGA, ON , Aug. 7, 2025 /PRNewswire/ - Maple Leaf Foods Inc. ("Maple Leaf Foods" or the "Company") (TSX: MFI) today reported its financial results for the second quarter ended June 30, 2025.
Second Quarter Highlights
Executive Commentary
"The momentum in our business continued in the second quarter, delivering strong results with sales growth of over 8% and Adjusted EBITDA of $182 million , an increase of $41 million or 29% from the prior year," said Curtis Frank , President and Chief Executive Officer of Maple Leaf Foods. "This performance was fueled by improved profitability in the pork complex and profitable growth in our brand-led consumer packaged goods business, resulting in an Adjusted EBITDA margin of 13.3%, a year-over-year improvement of 210 basis points, and the further strengthening of our balance sheet. With a strong first half now behind us, we are well-positioned to deliver on our increased full-year 2025 Adjusted EBITDA outlook," added Mr. Frank.
"In parallel, we continue to make excellent progress toward completing the spin-off of Canada Packers, supported by resounding shareholder approval and accelerating operational readiness," Frank added. "This historic transaction will unlock significant shareholder value and establish two focused, market-leading companies. We remain firmly on track to complete the transaction in the second half of the year, delivering long-term value for all our stakeholders," concluded Mr. Frank.
Update on the Spin-off of Canada Packers
The Company is continuing to advance its operational readiness for the spin-off of its Pork Operations to create Canada Packers Inc. as a stand-alone public company. The transaction, which was approved by shareholders in June, will be implemented as a tax-free "butterfly reorganization" by way of a plan of arrangement and, subject to receipt of an advance tax ruling from the Canada Revenue Agency and final TSX approval, is on track to be completed in the last half of 2025 as planned.
Outlook
(i) | Maple Leaf reorganized its operating units in the first quarter as further defined in the section titled Financial Highlights. |
(ii) | Refer to the section titled Non-IFRS Financial Measures in this news release. |
(iii) | Maple Leaf defines investment grade leverage as typically operating below 3.0x Net Debt to Trailing Twelve Months Adjusted EBITDA. |
The Company currently expects relatively normal pork market conditions and a stable consumer environment to continue for the balance of the year which is reflected in its increased full year 2025 Adjusted EBITDA outlook. However, evolving macro-economic factors continue to influence the operating environment. These factors may have an impact on consumer sentiment, supply chain activity, access to markets, barriers to trade, markets and foreign exchange rates. The Company leverages its data-driven insights to stay close to these evolving circumstances and is confident in the resilience of its brands, business model and strategy to manage through prevailing economic conditions. At the same time, it recognizes that its ability to deliver its 2025 guidance could be impacted by these conditions, including the impact of tariffs between Canada and the U.S. The Company is continuing to closely monitor the evolving tariff landscape so that it is prepared to adapt quickly as circumstances change. It has already adapted to changes in consumer sentiment that have emerged, including launching brand campaigns in Canada that respond to the "buy Canadian" movement.
Financial Highlights
As part of the restructuring of its commercial and supply chain operations during 2024, the Company split its prepared foods operations into two operating units; Prepared Foods which encompasses its prepared meats and plant protein categories, and Poultry which encompasses its fresh poultry category. Maple Leaf Foods consists of three operating units: Prepared Foods, Poultry, and Pork which represent approximately 55%, 20%, and 25% of total Company revenue respectively.
As at or for the | As at or for the | |||||||||||
($ millions except earnings per share) (Unaudited) | three months ended June 30, | six months ended June 30, | ||||||||||
2025 | 2024 | Change | 2025 | 2024 | Change | |||||||
Sales (i) | $ 1,362.1 | $ 1,255.2 | 8.5 % | $ 2,603.4 | $ 2,402.5 | 8.4 % | ||||||
Gross profit | $ 235.7 | $ 131.2 | 79.6 % | $ 453.5 | $ 357.5 | 26.9 % | ||||||
Selling, general and administrative expenses | $ 113.0 | $ 116.6 | (3.1) % | $ 227.8 | $ 226.7 | 0.5 % | ||||||
Earnings (Loss) | $ 57.8 | $ (26.2) | nm (iii) | $ 107.3 | $ 25.4 | nm (iii) | ||||||
Basic Earnings (Loss) per Share | $ 0.47 | $ (0.21) | nm (iii) | $ 0.87 | $ 0.21 | nm (iii) | ||||||
Adjusted Operating Earnings (ii) | $ 122.8 | $ 78.1 | 57.2 % | $ 218.5 | $ 131.1 | 66.7 % | ||||||
Adjusted EBITDA (ii) | $ 181.6 | $ 140.9 | 28.9 % | $ 348.0 | $ 257.3 | 35.3 % | ||||||
Adjusted EBITDA Margin (ii) | 13.3 % | 11.2 % | 210 bps | 13.4 % | 10.7 % | 270 bps | ||||||
Adjusted EBT (ii) | $ 94.5 | $ 34.4 | nm (iii) | $ 169.3 | $ 44.8 | nm (iii) | ||||||
Adjusted Earnings per Share (ii) | $ 0.56 | $ 0.18 | nm (iii) | $ 0.99 | $ 0.22 | nm (iii) | ||||||
Free Cash Flow (ii) | $ 216.0 | $ 27.0 | nm (iii) | $ 202.4 | $ 100.7 | nm (iii) | ||||||
Net Debt (ii) | $ 1,344.2 | $ 1,723.1 | (22.0) % |
(i) | Quarterly amounts for 2024 have been adjusted to eliminate new sales agreements entered into during the year that contained an expectation of repurchase, which had previously been reported as external sales. |
(ii) | Refer to the section titled Non-IFRS Financial Measures in this news release. |
(iii) | Not meaningful. |
Sales for the second quarter of 2025 were $1,362.1 million compared to $1,255.2 million last year, an increase of 8.5%. Prepared Foods sales increased by 7.5% driven by pricing, improved mix, and volume growth. Poultry sales increased by 8.5% driven by improved channel mix tied to retail and foodservice volume growth, and pricing. Pork sales increased by 10.7% due to an increase in the number of hogs processed and higher average hog weights.
Year-to-date sales for 2025 were $2,603.4 million , compared to $2,402.5 million last year, an increase of 8.4%. Prepared Foods sales increased by 7.3% driven by pricing, improved mix, volume growth, and favourable foreign exchange impacts related to US sales. Poultry sales increased by 7.3% driven by improved channel mix tied to retail and foodservice volume growth, and pricing. Pork sales increased by 11.3% due to an increase in the number of hogs processed, higher average hog weights, and favourable foreign exchange impacts.
Gross profit for the second quarter of 2025 increased to $235.7 million (gross margin of 17.3%) compared to $131.2 million (gross margin of 10.4%) last year. The increase in gross profit was driven by an increase in mark-to-market valuation of biological assets and commodity futures contracts, improved pork market conditions, favourable volume and mix impacts in Prepared Foods and Poultry, and operating efficiencies inclusive of benefits from the investments in the London poultry and Bacon Centre of Excellence facilities. These factors were partially offset by increased trade promotions.
Year-to-date gross profit for 2025 was $453.5 million (gross margin of 17.4%) compared to $357.5 million (gross margin of 14.9%) last year. The increase in gross profit was driven by improved pork market conditions, favourable volume and mix impacts in Prepared Foods and Poultry, and lower start-up expenses. These factors were partially offset by increased trade promotions and a decrease in mark-to-market valuation of biological assets.
Selling, General and Administrative ("SG&A") expenses for the second quarter of 2025 were $113.0 million compared to $116.6 million last year. The decrease in SG&A expenses was primarily driven by lower consulting fees, which were partially offset by higher variable compensation.
Year-to-date SG&A expenses for 2025 were $227.8 million compared to $226.7 million last year. The increase in SG&A expenses was driven by higher variable compensation and higher advertising and promotional expenses, which were partially offset by lower consulting fees.
Earnings for the second quarter of 2025 were $57.8 million ( $0.47 basic earnings per share) compared to a loss of $26.2 million ( $0.21 basic loss per share) last year. Earnings were impacted by the same factors as noted above for gross profit and SG&A as well as reduced interest expense due to lower debt, all partly offset by higher income tax expense as well as incremental costs associated with the upcoming spin-off of the Pork Operations and certain costs associated with the "Fuel for Growth" initiative, both of which were recorded outside of Adjusted Operating Earnings.
Year-to-date earnings for 2025 were $107.3 million ( $0.87 basic earnings per share) compared to $25.4 million ( $0.21 basic earnings per share) last year. Year-to-date earnings were impacted by the same factors as noted above for gross profit and SG&A, as well as reduced interest expense due to lower debt, all partly offset income tax expenses and by incremental costs associated with the upcoming spin-off of the Pork Operations and the "Fuel for Growth" initiative, both of which were recorded outside of Adjusted Operating Earnings.
Adjusted Operating Earnings for the second quarter of 2025 were $122.8 million compared to $78.1 million last year, and Adjusted Earnings per Share for the second quarter of 2025 was $0.56 compared to $0.18 last year. The increase was driven by factors consistent with those noted above for gross profit and SG&A expenses, excluding the impact of unrealized mark-to-market valuation adjustments.
Year-to-date Adjusted Operating Earnings for 2025 were $218.5 million compared to $131.1 million last year, and Adjusted Earnings per Share for 2025 was $0.99 compared to $0.22 last year due to factors consistent with those noted above for gross profit and SG&A expenses excluding the impact of unrealized mark-to-market valuation adjustments and start-up expenses.
Adjusted EBITDA for the second quarter was $181.6 million , compared to $140.9 million last year, driven by factors consistent with those noted above for Adjusted Operating Earnings. Adjusted EBITDA Margin was 13.3% compared to 11.2% last year, also driven by factors consistent with those noted above.
Year-to-date Adjusted EBITDA for 2025 was $348.0 million compared to $257.3 million last year, driven by factors consistent with those noted above for Adjusted Operating Earnings along with reduction of other expense. Year-to-date Adjusted EBITDA Margin for 2025 was 13.4% compared to 10.7% last year, also driven by factors consistent with those noted above.
Adjusted Earnings Before Taxes ("Adjusted EBT") for the second quarter of 2025 were $94.5 million compared to $34.4 million last year due to similar factors as noted above for Adjusted EBITDA, along with a reduction in interest expense.
Year-to-date Adjusted EBT for 2025 were $169.3 million compared to $44.8 million last year due to similar factors as noted above for the second quarter.
Free Cash Flow for the second quarter of 2025 was $216.0 million compared to Free Cash Flow of $27.0 million in the prior year. The improvement was driven by improved earnings after the removal of non-cash items, and timing impacts related to the change in non-cash working capital.
Year-to-date Free Cash Flow for 2025 was $202.4 million compared to Free Cash Flow of $100.7 million in the prior year. Free Cash Flow increased significantly due to improved earnings after the removal of non-cash items, timing impacts related to the change in non-cash working capital, and lower interest payments.
Net Debt as at June 30, 2025 was $1,344.2 million , a decrease of $378.8 million compared to the prior year.
Note: Several items are excluded from the discussions of underlying earnings performance as they are not representative of ongoing operational activities. Refer to the section entitled Non-IFRS Financial Measures at the end of this news release for a description and reconciliation of all non-IFRS financial measures. |
Other Matters
On August 6, 2025 , the Board of Directors approved a quarterly dividend of $0.24 per share, $0.96 per share on an annual basis, payable September 29, 2025 , to shareholders of record at the close of business on September 5, 2025 . Unless indicated otherwise by the Company at or before the time the dividend is paid, the dividend will be considered an eligible dividend for the purposes of the "Enhanced Dividend Tax Credit System". The Company's Dividend Reinvestment Plan ("DRIP") permits eligible shareholders to direct their cash dividends to be reinvested in additional common shares of the Company. The Company eliminated the 2% discount on the treasury shares issued under the DRIP beginning in 2025. Therefore, for shareholders who wish to reinvest their dividends under the DRIP, Maple Leaf Foods intends to issue common shares from treasury at a price equal to 100% of the weighted average closing price of the shares for the five trading days preceding the dividend payment date. Full details of the DRIP, including how to enroll in the program, are available at https://www.mapleleaffoods.com/ .
Conference Call
A conference call will be held at 8:30 a.m. ET on August 7, 2025, to review Maple Leaf Foods' second quarter financial results. To participate in the call, please dial 416-945-7677 or 1-888-699-1199. For those unable to participate, playback will be made available an hour after the event at 289-819-1450 or 1-888-660-6345 (Passcode: 00409#).
A webcast of the second quarter conference call will also be available at: https://www.mapleleaffoods.com/investors/events-and-presentations/ .
The Company's full unaudited condensed consolidated interim financial statements ("Consolidated Interim Financial Statements") and related Management's Discussion and Analysis are available on the Company's website and on SEDAR+ at www.sedarplus.ca .
An investor presentation related to the Company's second quarter financial results is available at www.mapleleaffoods.com under Presentations and Webcasts on the Investors page.
Non-IFRS Financial Measures
The Company uses the following non-IFRS measures: Adjusted Operating Earnings, Adjusted Earnings per Share, Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted EBT, Construction Capital, Net Debt, Net Debt to Trailing Twelve Months Adjusted EBITDA, Free Cash Flow and Return on Net Assets. Management believes that these non-IFRS measures provide useful information to investors in measuring the financial performance of the Company for the reasons outlined below. These measures do not have a standardized meaning prescribed by IFRS and therefore they may not be comparable to similarly titled measures presented by other publicly traded companies and should not be construed as an alternative to other financial measures determined in accordance with IFRS.
Adjusted Operating Earnings, Adjusted EBITDA, Adjusted EBITDA Margin and Adjusted EBT
Adjusted Operating Earnings, Adjusted EBITDA, Adjusted EBITDA Margin and Adjusted EBT are non-IFRS measures used by Management to evaluate financial operating results. Adjusted Operating Earnings is defined as earnings before income taxes adjusted for items that are not considered representative of ongoing operational activities of the business and certain items where the economic impact of the transactions will be reflected in earnings in future periods when the underlying asset is sold or transferred. Adjusted EBITDA is defined as Adjusted Operating Earnings plus depreciation and intangible asset amortization, adjusted for items included in other expense that are considered representative of ongoing operational activities of the business. Adjusted EBITDA Margin is calculated as Adjusted EBITDA divided by sales. Adjusted EBT is used annually by the Company to evaluate its performance and is a component of calculating bonus entitlements under the Company's short term incentive plan. It is defined as Adjusted EBITDA plus interest income, less depreciation and amortization, and interest expense and other financing costs.
The table below provides a reconciliation of earnings before income taxes as reported under IFRS in the Consolidated Interim Financial Statements to Adjusted Operating Earnings, Adjusted EBITDA and Adjusted EBT for the three and six months ended June 30, 2025 as indicated below. Management believes that these non-IFRS measures are useful in assessing the performance of the Company's ongoing operations and its ability to generate cash flows to fund its requirements.
Three months ended June 30, | Six months ended June 30, | |||
($ millions) (i) | 2025 | 2024 | 2025 | 2024 |
Earnings (loss) before income taxes | $ 81.0 | $ (32.5) | $ 151.6 | $ 41.3 |
Interest expense and other financing costs | 26.2 | 43.6 | 55.9 | 85.7 |
Other expense (income) | 12.8 | (3.5) | 14.0 | (2.3) |
Restructuring and other related costs | 2.7 | 6.9 | 4.2 | 6.2 |
Earnings from operations | $ 122.8 | $ 14.5 | $ 225.7 | $ 130.8 |
Start-up expenses from Construction Capital (ii) | 0.8 | 4.4 | 2.2 | 15.8 |
Decrease (increase) in fair value of biological assets | 8.1 | 52.5 | (8.3) | (16.7) |
Decrease (increase) in derivative contracts | (8.9) | 6.8 | (1.0) | 1.1 |
Adjusted Operating Earnings | $ 122.8 | $ 78.1 | $ 218.5 | $ 131.1 |
Depreciation and amortization (iii) | 61.5 | 63.7 | 124.1 | 128.6 |
Items included in other income (expense) representative of | (2.7) | (0.9) | 5.3 | (2.4) |
Adjusted EBITDA | $ 181.6 | $ 140.9 | $ 348.0 | $ 257.3 |
Adjusted EBITDA Margin (v) | 13.3 % | 11.2 % | 13.4 % | 10.7 % |
Interest expense and other financing costs | (26.2) | (43.6) | (55.9) | (85.7) |
Interest income | 0.6 | 0.8 | 1.3 | 1.8 |
Depreciation and amortization | (61.5) | (63.7) | (124.1) | (128.6) |
Adjusted EBT | $ 94.5 | $ 34.4 | $ 169.3 | $ 44.8 |
(i) | Totals may not add due to rounding. |
(ii) | Start-up expenses are temporary costs as a result of operating new facilities that are or were previously classified as Construction Capital. These costs can include training, product testing, yield and labour efficiency variances, duplicative overheads including depreciation and other temporary expenses required to ramp-up production. |
(iii) | Depreciation included in start-up expenses is excluded from this line. |
(iv) | Primarily includes certain costs associated with sustainability projects, gains and losses on the impairment and sale of long-term assets, gains and losses on investments and other miscellaneous expenses. |
(v) | Quarterly amounts for 2024 have been adjusted to eliminate new sales agreements entered into during the year that contained an expectation of repurchase, which had previously been reported as external sales. |
Adjusted Earnings per Share
Adjusted Earnings per Share, a non-IFRS measure, is used by Management to evaluate financial operating results. It is defined as basic earnings per share and is adjusted on the same basis as Adjusted Operating Earnings. The table below provides a reconciliation of basic earnings per share as reported under IFRS in the Consolidated Interim Financial Statements to Adjusted Earnings per Share for the three and six months ended June 30 as indicated below. Management believes this basis is the most appropriate on which to evaluate financial results as they are representative of the ongoing operations of the Company.
($ per share) (Unaudited) | Three months ended June 30, | Six months ended June 30, | ||||||
2025 | 2024 | 2025 | 2024 | |||||
Basic earnings (loss) per share | $ 0.47 | $ (0.21) | $ 0.87 | $ 0.21 | ||||
Restructuring and other related costs (i) | 0.02 | 0.04 | 0.03 | 0.04 | ||||
Items included in other expense not considered | 0.07 | (0.03) | 0.14 | (0.02) | ||||
Start-up expenses from Construction Capital (iii) | 0.01 | 0.03 | 0.01 | 0.10 | ||||
Change in fair value of biological assets | 0.05 | 0.31 | (0.05) | (0.12) | ||||
Change in unrealized and deferred fair value on derivatives | (0.05) | 0.04 | (0.01) | 0.01 | ||||
Adjusted Earnings per Share(iv) | $ 0.56 | $ 0.18 | $ 0.99 | $ 0.22 |
(i) | Includes per share impact of restructuring and other related costs, net of tax. |
(ii) | Primarily includes legal fees, vacancy costs on investment property, transaction related costs and costs associated with "Fuel for Growth", net of tax. |
(iii) | Start-up expenses are temporary costs as a result of operating new facilities that are or were previously classified as Construction Capital. These costs can include training, product testing, yield and labour efficiency variances, duplicative overheads and other temporary expenses required to ramp-up production, net of tax. |
(iv) | Totals may not add due to rounding. |
Construction Capital
Construction Capital, a non-IFRS measure, is used by Management to evaluate the amount of capital resources invested in specific strategic development projects that are not yet operational. It is defined as investments and related financing charges in projects over $50 million that are related to longer-term strategic initiatives, with no returns expected for at least 12 months from commencement of construction and the asset is re-categorized from Construction Capital once operational. There were no Construction Capital projects during the three and six months ended June 30, 2025 or June 30, 2024 as all projects had been completed and recategorized as regular property and equipment.
Net Debt
The following table reconciles Net Debt and Net Debt to Trailing Twelve Months Adjusted EBITDA ratio to amounts reported under IFRS in the Company's Consolidated Interim Financial Statements as at June 30 as indicated below. The Company calculates Net Debt as cash and cash equivalents, less current and long-term debt and bank indebtedness and calculates Net Debt to Trailing Twelve Months Adjusted EBITDA as the absolute value of Net Debt divided by Trailing Twelve Months Adjusted EBITDA. Management believes this measure is useful in assessing the amount of financial leverage employed.
($ thousands) (Unaudited) | As at June 30, | ||||||
2025 | 2024 | ||||||
Cash and cash equivalents | $ 236,045 | $ 158,381 | |||||
Current portion of long-term debt | $ (351,673) | $ (300,371) | |||||
Long-term debt | (1,228,599) | (1,581,093) | |||||
Total debt | $(1,580,272) | $(1,881,464) | |||||
Net Debt | $(1,344,227) | $(1,723,083) | |||||
Trailing Twelve Months Adjusted EBITDA (i) | $ 643,865 | $ 506,468 | |||||
Net Debt to Trailing Twelve Months Adjusted EBITDA | 2.1 | 3.4 | |||||
(i) | Trailing Twelve Months includes Q3 2024, Q4 2024, Q1 2025, and Q2 2025 for 2025; and Q3 2023, Q4 2023, Q1 2024, and Q2 2024 for 2024. |
Free Cash Flow
Free Cash Flow, a non-IFRS measure, is used by Management to evaluate cash flow after investing in the maintenance of the Company's asset base. It is defined as cash provided by operations, less Maintenance Capital (i) and associated interest paid and capitalized. The following table calculates Free Cash Flow for the periods indicated below:
($ thousands) (Unaudited) | Three months ended June 30, | Six months ended June 30, | ||||||
2025 | 2024 | 2025 | 2024 | |||||
Cash provided by operating activities | $ 239,587 | $ 45,496 | $ 249,470 | $ 132,821 | ||||
Maintenance Capital (i) | (23,276) | (18,250) | (46,516) | (31,686) | ||||
Interest paid and capitalized related to | (285) | (220) | (555) | (483) | ||||
Free Cash Flow | $ 216,026 | $ 27,026 | $ 202,399 | $ 100,652 |
(i) | Maintenance Capital is defined as non-discretionary investment required to maintain the Company's existing operations and competitive position. For the three and six months ended June 30, 2025, total capital spending of $24.4 millionand $49.3 million (2024: $16.3 million and $40.1 million) shown on the Consolidated Interim Statements of Cash Flows is made up of Maintenance Capital of $23.3 million and $46.5 million (2024: $18.3 million and $31.7 million), and Growth Capital of $1.1 million for the three months ended June 30, 2025 and $2.8 million for the six months ended June 30, 2025 (2024: net inflow of $2.0 million as a result of government grants received and a net outflow of $8.4 million). Growth Capital is defined as discretionary investment meant to create stakeholder value through initiatives that for example, expand margins, increase capacities or create further competitive advantage. |
Return on Net Assets ("RONA")
RONA is calculated by dividing tax effected earnings from operations (adjusted for items which are not considered representative of the underlying operations of the business) by average monthly net assets. Net assets are defined as total assets (excluding cash and deferred tax assets) less non-interest bearing liabilities (excluding deferred tax liabilities). Management believes that RONA is an appropriate basis upon which to evaluate long-term financial performance.
Forward-Looking Statements
This document contains, and the Company's oral and written public communications often contain, "forward-looking information" within the meaning of applicable securities law. These statements are based on current expectations, estimates, projections, beliefs, judgements and assumptions based on information available at the time the applicable forward-looking statement was made and in light of the Company's experience combined with its perception of historical trends. Such statements include, but are not limited to, statements with respect to objectives and goals, in addition to statements with respect to beliefs, plans, targets, goals, objectives, expectations, anticipations, estimates, and intentions. Forward-looking statements are typically identified by words such as "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "could", "would", "believe", "plan", "intend", "design", "target", "undertake", "view", "indicate", "maintain", "explore", "entail", "schedule", "objective", "strategy", "likely", "potential", "outlook", "aim", "propose", "goal", and similar expressions suggesting future events or future performance. These statements are not guarantees of future performance and involve assumptions, risks and uncertainties that are difficult to predict.
By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. The Company believes the expectations reflected in the forward-looking statements are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward-looking statements should not be unduly relied upon.
Specific forward-looking information in this document may include, but is not limited to, statements with respect to:
Various factors or assumptions are typically applied by the Company in drawing conclusions or making the forecasts, projections, predictions or estimations set out in the forward-looking statements. These factors and assumptions are based on information currently available to the Company, including information obtained by the Company from third-party sources and include but are not limited to the following:
Readers are cautioned that these assumptions may prove to be incorrect in whole or in part. The Company's actual results may differ materially from those anticipated in any forward-looking statements.
Factors that could cause actual results or outcomes to differ materially from the results expressed, implied, or projected in the forward-looking statements contained in this document include, among other things, risks associated with the following:
The Company cautions readers that the foregoing list of factors is not exhaustive.
Readers are further cautioned that some of the forward-looking information, such as statements concerning future capital expenditures, Adjusted EBITDA expectations, Adjusted EBITDA Margin expansion, and the Company's ability to achieve its financial targets or projections may be considered to be financial outlooks for purposes of applicable securities legislation. These financial outlooks are presented to evaluate potential future earnings and anticipated future uses of cash flows and may not be appropriate for other purposes. Readers should not assume these financial outlooks will be achieved.
More information about risk factors can be found under the heading "Risk Factors" in the Company's Annual Management's Discussion and Analysis for the year ended December 31, 2024 , that is available on SEDAR+ at www.sedarplus.ca . The reader should review such section in detail. Additional information concerning the Company, including the Company's Annual Information Form, is available on SEDAR+ at www.sedarplus.ca .
All forward-looking statements included herein speak only as of the date hereof. Unless required by law, the Company does not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. All forward-looking statements contained herein are expressly qualified by this cautionary statement.
Management's Estimates on the Pork Operations spin-off, and related Non-IFRS measures
The following tables present Management's preliminary estimates of certain financial information regarding Canada Packers and the business that will be retained after the separation by Maple Leaf Foods. These preliminary estimates have not been audited or reviewed by any third party, have been derived from internal management reporting, and reflect sales, cost and expense allocations, including with respect to corporate expenses, as well as other estimates and adjustments, each of which is preliminary in nature and subject to change.
Management believes that these preliminary estimates are useful in providing an indication of the relative size of the businesses upon separation. These preliminary estimates continue to be refined as the Company works to finalize the separation.
Quarter ended June 30, 2025 | ||||||||
(in millions of Canadian dollars) (unaudited) | Canada | Maple Leaf | Eliminations | Consolidated | ||||
Sales (IFRS) | $ 473 | (ii) | $ 1,001 | (iii) | $ (112) | (iv) | $ 1,362 | (v) |
Estimate of potential impact of separation (vi) | (17) | 18 | ||||||
Pro Forma Sales | $ 456 | $ 1,019 | ||||||
Adjusted EBITDA | $ 52 | (vii) | $ 130 | (viii) | — | $ 182 | (v),(ix) | |
Adjusted EBITDA Margin * | 11.0 % | 13.0 % | — % | 13.3 % | ||||
Estimate of potential impact of separation (xi) | ~$(7) | ~$5 | ||||||
Pro Forma Adjusted EBITDA (xii) | ~$45 | ~$134 | ||||||
Pro Forma Adjusted EBITDA margin (xiii) | ~10% | ~13% | ||||||
Estimate of potential market normalization impact (xiv) | ~$3 - 6 | |||||||
Pro Forma normalized Adjusted EBITDA (xv) | ~$50 | |||||||
Pro Forma normalized Adjusted EBITDA Margin (xvi) | ~11% |
Notes | |
(i) | Refers to the business that will be retained after the separation by Maple Leaf Foods Inc. |
(ii) | Represents management's preliminary estimate of sales (both to Maple Leaf Foods and to external third parties) attributable to the business that will be transferred to Canada Packers in the separation for the period presented. |
(iii) | Represents management's preliminary estimate of sales attributable to the business that will be retained by Maple Leaf Foods after the separation for the period presented. |
(iv) | Primarily represents management's preliminary estimate of sales from Canada Packers to Maple Leaf Foods for the period presented. |
(v) | See the Company's Q2 2025 Consolidated Interim Financial Statements filed on SEDAR+ |
(vi) | Represents management's preliminary estimate of the potential impact on Sales of Canada Packers and Maple Leaf Foods (as defined in note (i) above), respectively, if the separation had occurred on April 1, 2025. Primarily relates to management's preliminary estimate of the change in sales as a result of the anticipated impact of the supply agreement and other contractual arrangements expected to be entered into in connection with the separation. |
(vii) | Represents management's preliminary estimate of the portion of consolidated Adjusted EBITDA attributable to Canada Packers for the period presented. As noted above, this estimate is subject to change as the Company works to finalize the separation. |
(viii) | Represents management's preliminary estimate of the portion of consolidated Adjusted EBITDA attributable to Maple Leaf Foods (as defined in note (i) above) for the period presented. As noted above, this estimate is subject to change as the Company works to finalize the separation. |
(ix) | For a definition of Adjusted EBITDA (consolidated), and a reconciliation of Adjusted EBITDA (consolidated) for the periods described in note (v) above to consolidated net income for such periods, see the Company's MD&A filed on SEDAR+ for the quarter ended June 30, 2025. |
* | Defined as Adjusted EBITDA divided by Sales. This metric is subject to change as the Company works to finalize the separation in the same manner as the metrics from which this metric is derived, as noted above. |
(xi) | Represents management's preliminary estimate of the potential impact on Adjusted EBITDA of Canada Packers and Maple Leaf Foods (as defined in note (i) above), respectively, if the separation had occurred on April 1, 2025. Primarily relates to management's preliminary estimate of (1) a change in Adjusted EBITDA of Canada Packers and an offsetting change in Adjusted EBITDA of Maple Leaf Foods as a result of the anticipated impact of the supply agreement and other contractual arrangements expected to be entered into in connection with the separation, (2) public company costs that would have been incurred by Canada Packers, and (3) a reallocation of certain SG&A expenses between Canada Packers and Maple Leaf Foods. As noted above, this estimate is subject to change and is expected to be refined prior to the separation. |
(xii) | Defined as Adjusted EBITDA plus management's preliminary estimate of the potential impact of the separation described in, and subject to the qualifications described in, note (xi) above. |
(xiii) | Defined as Pro Forma Adjusted EBITDA, as described in note (xii) above divided by Pro Forma Sales. This metric is subject to change as the Company works to finalize the separation in the same manner as the metrics from which this metric is derived, as noted above. |
(xiv) | Presented for illustrative purposes only, based on management estimates and assumptions, to indicate what the potential impact on Pro Forma Adjusted EBITDA may have been if market conditions during the period presented had reflected normal market conditions, defined as the 5-year pre-pandemic (2015 – 2019) average ("Normal Market Conditions"). Actual market conditions during the period presented were materially different from Normal Market Conditions, and there can be no assurance that actual Pro Forma Adjusted EBITDA would have been impacted in the manner shown if Normal Market Conditions had existed during the period presented, or that actual future market conditions will reflect Normal Market Conditions. This metric is not intended to be indicative of potential financial results for any future period. |
(xv) | Defined as Pro Forma Adjusted EBITDA, as described in note (xi) above, plus management's preliminary estimate of the potential impact if market conditions during the period presented had reflected Normal Market Conditions, subject to the qualifications described in note (xiv) above. This metric is presented for illustrative purposes only and is not intended to be indicative of potential financial results for any future period. |
(xvi) | Defined as Pro Forma normalized Adjusted EBITDA, as described in note (xiv) above, divided by Pro Forma Sales. This metric is presented for illustrative purposes only and is based on management estimates and assumptions. This metric is subject to change and is expected to be refined prior to the separation in the same manner as the metrics from which this metric is derived, as noted above. Actual market conditions during the period presented were materially different from Normal Market Conditions, and there can be no assurance that actual Pro Forma Adjusted EBITDA Margin would have been impacted in the manner shown if Normal Market Conditions had existed during the period presented, or that actual future market conditions will reflect Normal Market Conditions. This metric is not intended to be indicative of potential financial results for any future period. |
Last twelve months ended June 30, 2025 | ||||||||
(in millions of Canadian dollars) (unaudited) | Canada | Maple Leaf | Eliminations | Consolidated | ||||
Sales (IFRS) | $ 1,769 | (ii) | $ 3,751 | (iii) | $ (424) | (iv) | $ 5,096 | (v) |
Estimate of potential impact of separation (vi) | (77) | 71 | ||||||
Pro Forma Sales | $ 1,692 | $ 3,822 | ||||||
Adjusted EBITDA | $ 192 | (vii) | $ 452 | (viii) | — | $ 644 | (v),(ix) | |
Adjusted EBITDA Margin * | 10.9 % | 12.1 % | — % | 12.6 % | ||||
Estimate of potential impact of separation (xi) | ~$(21) | ~11 | ||||||
Pro Forma Adjusted EBITDA (xii) | ~$170 | ~$463 | ||||||
Pro Forma Adjusted EBITDA margin (xiii) | ~10% | ~12% | ||||||
Estimate of potential market normalization impact (xiv) | ~$30 - 40 | |||||||
Pro Forma normalized Adjusted EBITDA (xv) | ~$200 | |||||||
Pro Forma normalized Adjusted EBITDA Margin (xvi) | ~12% |
Notes | |
(i) | Refers to the business that will be retained after the separation by Maple Leaf Foods Inc. |
(ii) | Represents management's preliminary estimate of sales (both to Maple Leaf Foods and to external third parties) attributable to the business that will be transferred to Canada Packers in the separation for the period presented. |
(iii) | Represents management's preliminary estimate of sales attributable to the business that will be retained by Maple Leaf Foods after the separation for the period presented. |
(iv) | Primarily represents management's preliminary estimate of sales from Canada Packers to Maple Leaf Foods for the period presented. |
(v) | Calculated by adding the previously reported results for the year ended December 31, 2024 to results for the six months ended June 30, 2025 and subtracting results for the six months ended June 30, 2024. These results are reported in the Company's MD&A filed on SEDAR and SEDAR+ for the year ended December 31, 2024, the quarter ended June 30, 2025 and the quarter ended June 30, 2024. |
(vi) | Represents management's preliminary estimate of the potential impact on Sales of Canada Packers and Maple Leaf Foods (as defined in note (i) above), respectively, if the separation had occurred on June 30, 2024. Primarily relates to management's preliminary estimate of the change in sales as a result of the anticipated impact of the supply agreement and other contractual arrangements expected to be entered into in connection with the separation. |
(vii) | Represents management's preliminary estimate of the portion of consolidated Adjusted EBITDA attributable to Canada Packers for the period presented. As noted above, this estimate is subject to change as the Company works to finalize the separation. |
(viii) | Represents management's preliminary estimate of the portion of consolidated Adjusted EBITDA attributable to Maple Leaf Foods (as defined in note (i) above) for the period presented. As noted above, this estimate is subject to change as the Company works to finalize the separation. |
(ix) | For a definition of Adjusted EBITDA (consolidated), and a reconciliation of Adjusted EBITDA (consolidated) for the periods described in note (v) above to consolidated net income for such periods, see the Company's MD&A filed on SEDAR and SEDAR+ for the year ended December 31, 2024, the quarter ended June 30, 2025 and the quarter ended June 30, 2024. |
* | Defined as Adjusted EBITDA divided by Sales. This metric is subject to change as the Company works to finalize the separation in the same manner as the metrics from which this metric is derived, as noted above. |
(xi) | Represents management's preliminary estimate of the potential impact on Adjusted EBITDA of Canada Packers and Maple Leaf Foods (as defined in note (i) above), respectively, if the separation had occurred on June 30, 2024. Primarily relates to management's preliminary estimate of (1) a change in Adjusted EBITDA of Canada Packers and an offsetting change in Adjusted EBITDA of Maple Leaf Foods as a result of the anticipated impact of the supply agreement and other contractual arrangements expected to be entered into in connection with the separation, (2) public company costs that would have been incurred by Canada Packers, and (3) a reallocation of certain SG&A expenses between Canada Packers and Maple Leaf Foods. As noted above, this estimate is subject to change as the Company works to finalize the separation. |
(xii) | Defined as Adjusted EBITDA plus management's preliminary estimate of the potential impact of the separation described in, and subject to the qualifications described in, note (xi) above. |
(xiii) | Defined as Pro Forma Adjusted EBITDA, as described in note (xii) above divided by Pro Forma Sales. This metric is subject to change as the Company works to finalize the separation in the same manner as the metrics from which this metric is derived, as noted above. |
(xiv) | Presented for illustrative purposes only, based on management estimates and assumptions, to indicate what the potential impact on Pro Forma Adjusted EBITDA may have been if market conditions during the period presented had reflected normal market conditions, defined as the 5-year pre-pandemic (2015 – 2019) average ("Normal Market Conditions"). Actual market conditions during the period presented were materially different from Normal Market Conditions, and there can be no assurance that actual Pro Forma Adjusted EBITDA would have been impacted in the manner shown if Normal Market Conditions had existed during the period presented, or that actual future market conditions will reflect Normal Market Conditions. This metric is not intended to be indicative of potential financial results for any future period. |
(xv) | Defined as Pro Forma Adjusted EBITDA, as described in note (xi) above, plus management's preliminary estimate of the potential impact if market conditions during the period presented had reflected Normal Market Conditions, subject to the qualifications described in note (xiv) above. This metric is presented for illustrative purposes only and is not intended to be indicative of potential financial results for any future period. |
(xvi) | Defined as Pro Forma normalized Adjusted EBITDA, as described in note (xiv) above, divided by Pro Forma Sales.This metric is presented for illustrative purposes only and is based on management estimates and assumptions. This metric is subject to change and is expected to be refined prior to the separation in the same manner as the metrics from which this metric is derived, as noted above. Actual market conditions during the period presented were materially different from Normal Market Conditions, and there can be no assurance that actual Pro Forma Adjusted EBITDA Margin would have been impacted in the manner shown if Normal Market Conditions had existed during the period presented, or that actual future market conditions will reflect Normal Market Conditions. This metric is not intended to be indicative of potential financial results for any future period. |
Adjusted EBITDA, Pro Forma Adjusted EBITDA, and Pro Forma normalized Adjusted EBITDA, and related margins, as presented in the tables above, are non-IFRS metrics and do not have a standardized meaning prescribed by IFRS. Consequently, they may not be comparable to similarly titled measures presented by other publicly traded companies and should not be construed as an alternative to other financial measures determined in accordance with IFRS.
About Maple Leaf Foods Inc.
Maple Leaf Foods is a leading protein company responsibly producing food products under leading brands including Maple Leaf ® , Maple Leaf Prime ® , Maple Leaf Natural Selections ® , Schneiders ® , Mina ® , Greenfield Natural Meat Co. ® , Lightlife ® and Field Roast™. The Company's portfolio includes prepared meats, ready-to-cook and ready-to-serve meals, snack kits, value-added fresh pork and poultry, and plant protein products. The Company employs approximately 13,500 people and does business primarily in Canada , the U.S. and Asia . The Company is headquartered in Mississauga, Ontario and its shares trade on the Toronto Stock Exchange (MFI).
Consolidated Interim Balance Sheets
(In thousands of Canadian dollars) | As at June 30, | As at June 30, 2024 | As at December 31, | |||
ASSETS | ||||||
Cash and cash equivalents | $ 236,045 | $ 158,381 | $ 175,908 | |||
Accounts receivable | 175,559 | 184,300 | 170,919 | |||
Notes receivable | 45,510 | 44,886 | 37,978 | |||
Inventories | 602,370 | 580,472 | 553,398 | |||
Biological assets | 175,550 | 124,688 | 169,399 | |||
Income and other taxes recoverable | 2,474 | 62,761 | 7,551 | |||
Prepaid expenses and other assets | 39,155 | 35,203 | 42,342 | |||
Assets held for sale | — | 27,438 | 22,769 | |||
Total current assets | $ 1,276,663 | $ 1,218,129 | $ 1,180,264 | |||
Property and equipment | 2,058,069 | 2,186,520 | 2,123,167 | |||
Right-of-use assets | 149,272 | 171,692 | 160,922 | |||
Investments | 12,500 | 16,112 | 12,763 | |||
Investment property | 63,488 | 34,744 | 42,588 | |||
Employee benefits | 15,500 | 116,800 | 22,429 | |||
Other long-term assets | 23,624 | 22,271 | 24,918 | |||
Deferred tax asset | 45,808 | 42,504 | 46,588 | |||
Goodwill | 477,353 | 477,353 | 477,353 | |||
Intangible assets | 325,055 | 343,457 | 339,526 | |||
Total long-term assets | $ 3,170,669 | $ 3,411,453 | $ 3,250,254 | |||
Total assets | $ 4,447,332 | $ 4,629,582 | $ 4,430,518 | |||
LIABILITIES AND EQUITY | ||||||
Accounts payable and accruals | $ 628,257 | $ 543,792 | $ 561,179 | |||
Current portion of provisions | 9,182 | 9,673 | 14,482 | |||
Current portion of long-term debt | 351,673 | 300,371 | 301,478 | |||
Current portion of lease obligations | 39,710 | 40,544 | 39,900 | |||
Income taxes payable | 51,955 | 2,351 | 2,595 | |||
Other current liabilities | 29,342 | 24,986 | 37,587 | |||
Total current liabilities | $ 1,110,119 | $ 921,717 | $ 957,221 | |||
Long-term debt | 1,228,599 | 1,581,093 | 1,390,479 | |||
Lease obligations | 136,631 | 157,550 | 147,892 | |||
Employee benefits | 61,837 | 60,796 | 62,395 | |||
Provisions | 3,122 | 1,998 | 3,912 | |||
Other long-term liabilities | 4,961 | 1,167 | 5,205 | |||
Deferred tax liability | 313,939 | 330,232 | 325,137 | |||
Total long-term liabilities | $ 1,749,089 | $ 2,132,836 | $ 1,935,020 | |||
Total liabilities | $ 2,859,208 | $ 3,054,553 | $ 2,892,241 | |||
Shareholders' equity | ||||||
Share capital | $ 904,226 | $ 886,876 | $ 897,839 | |||
Retained earnings | 631,839 | 640,589 | 587,393 | |||
Contributed surplus | 14,049 | 6,773 | 12,482 | |||
Accumulated other comprehensive income | 38,642 | 44,222 | 43,994 | |||
Treasury shares | (632) | (3,431) | (3,431) | |||
Total shareholders' equity | $ 1,588,124 | $ 1,575,029 | $ 1,538,277 | |||
Total liabilities and equity | $ 4,447,332 | $ 4,629,582 | $ 4,430,518 |
Consolidated Interim Statements of Earnings (Loss)
(In thousands of Canadian dollars, except share amounts) (Unaudited) | Three months ended June 30, | Six months ended June 30, | ||||||
2025 | 2024 (i) | 2025 | 2024 (i) | |||||
Sales | $ 1,362,144 | $ 1,255,173 | $ 2,603,437 | $ 2,402,464 | ||||
Cost of goods sold | 1,126,427 | 1,124,018 | 2,149,946 | 2,044,969 | ||||
Gross profit | $ 235,717 | $ 131,155 | $ 453,491 | $ 357,495 | ||||
Selling, general and administrative expenses | 112,966 | 116,649 | 227,773 | 226,682 | ||||
Earnings before the following: | $ 122,751 | $ 14,506 | $ 225,718 | $ 130,813 | ||||
Restructuring and other related costs | 2,705 | 6,893 | 4,208 | 6,168 | ||||
Other expense (income) | 12,789 | (3,492) | 14,022 | (2,335) | ||||
Earnings before interest and income taxes | $ 107,257 | $ 11,105 | $ 207,488 | $ 126,980 | ||||
Interest expense and other financing costs | 26,234 | 43,637 | 55,880 | 85,720 | ||||
Earnings (loss) before income taxes | $ 81,023 | $ (32,532) | $ 151,608 | $ 41,260 | ||||
Income tax expense (recovery) | 23,245 | (6,359) | 44,267 | 15,882 | ||||
Earnings (loss) | $ 57,778 | $ (26,173) | $ 107,341 | $ 25,378 | ||||
Earnings (loss) per share attributable to common shareholders: | ||||||||
Basic earnings (loss) per share | $ 0.47 | $ (0.21) | $ 0.87 | $ 0.21 | ||||
Diluted earnings (loss) per share | $ 0.46 | $ (0.21) | $ 0.86 | $ 0.20 | ||||
Weighted average number of shares (millions): | ||||||||
Basic | 123.9 | 122.9 | 123.8 | 122.7 | ||||
Diluted | 125.6 | 122.9 | 125.3 | 123.8 |
(i) | Quarterly amounts for 2024 have been adjusted. See Note 16 in the condensed consolidated interim financial statements as filed on SEDAR+ at www.sedarplus.ca. |
Consolidated Interim Statements of Other Comprehensive Income
(In thousands of Canadian dollars) (Unaudited) | Three months ended June 30, | Six months ended June 30, | ||||||
2025 | 2024 | 2025 | 2024 | |||||
Earnings (loss) | $ 57,778 | $ (26,173) | $ 107,341 | $ 25,378 | ||||
Other comprehensive (loss) income | ||||||||
Actuarial gains (losses) that will not be reclassified | $ (7,453) | $ 65,346 | $ (3,319) | $ 71,951 | ||||
Total items that will not be reclassified to profit or loss | $ (7,453) | $ 65,346 | $ (3,319) | $ 71,951 | ||||
Items that are or may be reclassified subsequently to profit or loss: | ||||||||
Change in accumulated foreign currency | (20,338) | 3,401 | (20,365) | 11,111 | ||||
Change in foreign exchange on long-term debt million and $1.8 million) | 15,230 | (3,226) | 15,343 | (9,838) | ||||
Change in cash flow hedges (Net of tax of $0.0 | (76) | (1,258) | (330) | (4,880) | ||||
Total items that are or may be reclassified subsequently to profit or loss | $ (5,184) | $ (1,083) | $ (5,352) | $ (3,607) | ||||
Total other comprehensive (loss) income | $ (12,637) | $ 64,263 | $ (8,671) | $ 68,344 | ||||
Comprehensive income | $ 45,141 | $ 38,090 | $ 98,670 | $ 93,722 |
Consolidated Interim Statements of Changes in Total Equity
Accumulated other comprehensive income (loss) | |||||||||
(In thousands of Canadian dollars) (Unaudited) | Share capital | Retained earnings | Contributed surplus | Foreign | Unrealized | Unrealized | Revaluation | Treasury shares | Total equity |
Balance at December 31, 2024 | $ 897,839 | 587,393 | 12,482 | 14,545 | (1,257) | (6,641) | 37,347 | (3,431) | $ 1,538,277 |
Earnings | — | 107,341 | — | — | — | — | — | — | 107,341 |
Other comprehensive income (loss) (ii) | — | (3,319) | — | (5,022) | (330) | — | — | — | (8,671) |
Dividends declared ($0.48 per share) | 5,695 | (59,576) | — | — | — | — | — | — | (53,881) |
Share-based compensation expense | — | — | 12,406 | — | — | — | — | — | 12,406 |
Deferred taxes on share-based compensation | — | — | 3,175 | — | — | — | — | — | 3,175 |
Exercise of stock options | 692 | — | — | — | — | — | — | — | 692 |
Shares purchased by RSU trust | — | — | — | — | — | — | — | (4,094) | (4,094) |
Settlement of share-based compensation | — | — | (14,014) | — | — | — | — | 6,893 | (7,121) |
Balance at June 30, 2025 | $ 904,226 | 631,839 | 14,049 | 9,523 | (1,587) | (6,641) | 37,347 | (632) | $ 1,588,124 |
Accumulated other comprehensive income (loss) (i) | |||||||||
(In thousands of Canadian dollars) (Unaudited) | Share capital | Retained earnings | Contributed surplus | Foreign | Unrealized | Unrealized value of | Revaluation | Treasury shares | Total equity |
Balance at December 31, 2023 | $ 873,477 | 597,429 | 3,227 | 8,625 | 4,416 | (2,559) | 37,347 | (7,183) | $ 1,514,779 |
Earnings | — | 25,378 | — | — | — | — | — | — | 25,378 |
Other comprehensive income (loss) (ii) | — | 71,951 | — | 1,273 | (4,880) | — | — | — | 68,344 |
Dividends declared ($0.44 per share) | 10,901 | (54,169) | — | — | — | — | — | — | (43,268) |
Share-based compensation expense | — | — | 11,387 | — | — | — | — | — | 11,387 |
Deferred taxes on share-based compensation | — | — | (425) | — | — | — | — | — | (425) |
Exercise of stock options | 2,498 | — | — | — | — | — | — | — | 2,498 |
Settlement of share-based compensation | — | — | (7,416) | — | — | — | — | 3,752 | (3,664) |
Balance at June 30, 2024 | $ 886,876 | 640,589 | 6,773 | 9,898 | (464) | (2,559) | 37,347 | (3,431) | $ 1,575,029 |
(i) | Items that are or may be subsequently reclassified to profit or loss. |
(ii) | Included in other comprehensive income (loss) is the change in actuarial gains and losses that will not be reclassified to profit or loss and has been reclassified to retained earnings. |
Consolidated Interim Statements of Cash Flows
(In thousands of Canadian dollars) (Unaudited) | Three months ended June 30, | Six months ended June 30, | ||||||
2025 | 2024 | 2025 | 2024 | |||||
CASH PROVIDED BY (USED IN): | ||||||||
Operating activities | ||||||||
Earnings (loss) | $ 57,778 | $ (26,173) | $ 107,341 | $ 25,378 | ||||
Add (deduct) items not affecting cash: | ||||||||
Change in fair value of biological assets | 8,087 | 52,488 | (8,324) | (16,655) | ||||
Depreciation and amortization | 62,103 | 64,446 | 125,757 | 130,299 | ||||
Share-based compensation | 6,629 | 6,089 | 12,406 | 11,387 | ||||
Deferred income tax (recovery) expense | (8,237) | (8,843) | (11,954) | 11,093 | ||||
Current income tax expense | 31,482 | 2,484 | 56,221 | 4,789 | ||||
Interest expense and other financing costs | 26,234 | 43,637 | 55,880 | 85,720 | ||||
Gain on sale of long-term assets | — | (1,326) | (10,609) | (1,637) | ||||
Impairment of property and equipment and right-of-use assets | 1,291 | 118 | 2,157 | 118 | ||||
Change in fair value of long-term assets | — | (5,038) | — | (5,038) | ||||
Change in fair value of non-designated derivatives | (744) | 2,991 | 378 | (1,674) | ||||
Change in net pension obligation | 1,233 | 2,169 | 1,952 | 3,236 | ||||
Net income taxes (paid) refunded | (229) | 18,764 | (1,594) | 21,746 | ||||
Interest paid, net of capitalized interest | (26,127) | (32,459) | (54,700) | (72,936) | ||||
Change in provision for restructuring and other related costs | (1,788) | 3,087 | (6,051) | (173) | ||||
Change in derivatives margin | 3,650 | (1,075) | 2,039 | 1,241 | ||||
Cash settlement of derivatives | — | (728) | — | (2,878) | ||||
Other | (23,549) | 2,231 | (18,404) | 5,324 | ||||
Change in non-cash operating working capital | 101,774 | (77,366) | (3,025) | (66,519) | ||||
Cash provided by operating activities | $ 239,587 | $ 45,496 | $ 249,470 | $ 132,821 | ||||
Investing activities | ||||||||
Additions to long-term assets | $ (24,433) | $ (16,318) | $ (49,285) | $ (40,131) | ||||
Interest paid and capitalized | (303) | (219) | (583) | (574) | ||||
Proceeds from sale of long-term assets | 1,750 | 2,631 | 14,754 | 3,496 | ||||
Cash used in investing activities | $ (22,986) | $ (13,906) | $ (35,114) | $ (37,209) | ||||
Financing activities | ||||||||
Dividends paid | $ (27,150) | $ (21,607) | $ (53,881) | $ (43,268) | ||||
Net decrease in long-term debt | (60,265) | (50,480) | (80,047) | (81,365) | ||||
Payment of lease obligation | (8,091) | (7,891) | (16,183) | (16,337) | ||||
Exercise of stock options | 534 | 2,498 | 534 | 2,498 | ||||
Purchase of treasury shares | (4,094) | — | (4,094) | — | ||||
Payment of financing fees | (541) | (2,122) | (548) | (2,122) | ||||
Cash used in financing activities | $ (99,607) | $ (79,602) | $ (154,219) | $ (140,594) | ||||
Increase (decrease) in cash and cash equivalents | $ 116,994 | $ (48,012) | $ 60,137 | $ (44,982) | ||||
Cash and cash equivalents, beginning of period | 119,051 | 206,393 | 175,908 | 203,363 | ||||
Cash and cash equivalents, end of period | $ 236,045 | $ 158,381 | $ 236,045 | $ 158,381 |
SOURCE Maple Leaf Foods Inc.
Analys
Novo Nordisk
Bostadsmarknaden
Trumps handelskrig
Inflationen
Fonder
Aktieråd
Analys
Novo Nordisk
Bostadsmarknaden
Trumps handelskrig
Inflationen
Fonder
Aktieråd
Nyfosa
Igår, 16:35
Nyfosas VD köper aktier
OMX Stockholm 30
1 DAG %
Senast
2 602,98